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 SUMMARY 
 
Ingested dietary proteins are cleaved into small oligopeptides and single amino acids 
that are then absorbed across small intestine enterocytes. Similarly, small oligopeptides 
and single amino acids are reabsorbed across kidney proximal tubule epithelial cells to 
prevent their loss in the urine. The first step of this transcellular transport is the influx 
across the luminal brush border membrane that is mediated by symporters 
(cotransporters) and antiporters (exchangers). The basolateral efflux of amino acids 
from the epithelial cells into the extracellular space is mediated by (a) facilitated diffusion 
pathway(s) and exchangers. 
The main focus of my doctoral thesis was the system B0 transport, which mediates the 
sodium-driven uptake of a broad range of neutral amino acids into epithelial cells of 
small intestine and kidney proximal tubule. For many years, the B0 transport system 
remained molecularly unidentified and only to some extent functionally characterized. 
The first B0-type transporter was identified in 2004 by Broer’s group. This transporter 
called B0AT1 (broad range neutral amino acid transporter 1) belongs to the mouse gene 
family Slc6 (SLC6 in human) of Na+-(and Cl-)-dependent (neurotransmitter) transporters. 
Its function as Na+-dependent neutral amino acid cotransporter was demonstrated by 
flux- and electrophysiological measurements of transporter expressed in Xenopus laevis 
oocytes. Unlike other members of the SLC6 family, its function does not depend on the 
presence of Cl-, as expected for system B0. The orthologue human gene SLC6A19 
localizes to chromosome 5p15.33 and its defect was shown by us together with others to 
cause Hartnup disorder, an autosomal recessive condition characterized by an increase 
in the urinary excretion of neutral amino acids. This amino aciduria is often 
asymptomatic but can be accompanied by pellagra-like skin rash, attacks of cerebellar 
ataxia and other neurological or psychiatric symptoms.  
Two quite similar human transporters called XT2 (Xtrp2) and XT3 (Xtrp3) have been 
identified earlier and represent the products of the genes SLC6A18 and 20. Together 
with B0AT1, they form a separate cluster within the SLC6 family. One of these genes, 
SLC6A18, is localized on chromosome 5p15.33, just next to SLC6A19, whereas 
SLC6A20 is on chromosome 3p21.3. In the mouse genome, there are two SLC6A20-
related genes arranged sequentially on chromosome 9 that probably have arisen from a 
duplication that took place after the evolutionary separation of rodents and primates. The 
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 first of these gene products identified in mice was named XT3, whereas the second one, 
XT3s1, is 90% identical to it but resembles, in terms of primary structure and tissue 
distribution, more human XT3. In human, the single XT3 gene gives rise by alternative 
splicing to two isoforms. One of these human XT3 isoforms and the rodent XT3s1 have 
been shown in 2005 to correspond to system imino, that transports L-Pro as well as 
some other substrates such as pipecolate and N-methylated amino acids (e.g. MeAIB 
and sarcosine) with a high apparent affinity and have correspondingly been renamed 
SIT1 or IminoB.  
The original studies on the still orphan transporter XT2 and mouse XT3 showed that 
their mRNAs are expressed in kidney and possibly also in small intestine. Expression 
experiments of XT2 and mouse XT3 in Xenopus laevis oocytes and in other expression 
systems have not revealed their function. A recently published study on a XT2 knock out 
mouse showed that these mice loose some glycine in their urine and possibly little 
quantities of other neutral amino acids as well, suggesting that this transporter might 
similarly to B0AT1 transport amino acids.  
In the first part of my doctoral thesis, I focused on the production of a knockout mouse 
for XT3. Because of several technical problems, this project was discontinued after few 
months. 
Our interest moved then to the question of the putative role of these four B0AT1-related 
gene products in mouse. Therefore, we localized their expression by quantifying their 
mRNAs in different tissues using real time RT-PCR and tested their localization at the 
protein level in kidney and intestine using Western blotting an immunofluorescence. 
Furthermore, we tested in C57BL/6J mice subjected to low and high sodium diets or 
treatments inducing metabolic acidosis and alkalosis whether the regulation of these 
transporters at the mRNA and protein level in kidney plays a role.  Because these 
different treatments did not influence the expression of any of the transporters tested we 
concluded that they essentially play a constitutive role. 
Quantitative real-time RT-PCR showed that the mRNAs of the four B0AT-cluster 
members are abundant in kidney, whereas only those of B0AT1 and XT3s1/SIT1 are 
elevated in small intestine. In brain, the XT3s1/SIT1 mRNA was more abundant than the 
other B0AT-cluster mRNAs. We showed by immunofluorescence that all four mouse 
B0AT-cluster transporters localize, with differential axial gradients, to the brush border 
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 membrane of proximal kidney tubule and, with the possible exception of XT3, also of 
intestine. Deglycosylation and Western blotting of brush border proteins demonstrated 
the glycosylation and confirmed the luminal localization of B0AT1, XT2 and XT3.  
Taken together, the work performed during this PhD thesis has contributed to the 
characterization of the formerly orphan Slc6 transporters of the B0AT cluster. In 
particular, the localization studies have clarified the precise distribution of B0AT1 and the 
related transporters in the brush border membrane of kidney proximal tubule and small 
intestine. Furthermore, these studies have shown that the B0AT cluster transporters are 
constitutive elements of amino acid reabsorbing epithelia, subjected only to moderate 
regulatory changes, and set the basis for the detailed in vivo analysis of the mouse 
transporter XT2 (Slc6a18). 
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 ZUSAMMENFASSUNG 
 
 
Mit der Nahrung aufgenommene Proteine werden in kleine Oligopeptide und 
Aminosäuren gespalten, welche anschliessend im Dünndarm absorbiert werden. In 
ähnlicher Weise werden solche Oligopeptide und Aminosäuren im proximalen Tubulus 
der Niere über Epithelzellen reabsorbiert, um deren Ausscheidung mit dem Urin zu 
verhindern. Der erste Schritt dieses transzellulären Transportes ist die Aufnahme der 
Aminosäuren über die luminale Bürstensaummembran, was durch Symporter 
(Cotransporter) und Antiporter (Austauscher) gewährleistet wird. Der basolaterale Efflux 
der Aminosäuren aus den Epithelzellen in den extrazellulären Raum wird sowohl durch 
erleichterte Diffusion als auch durch Austauscher vermittelt. 
Der Hauptaspekt dieser Arbeit richtete sich auf das B0-Transportsystem, welches die 
Natrium-abhängige Aufnahme von neutralen Aminosäuren in Epithelzellen des 
Dünndarms und des proximalen Tubulus in der Niere vermittelt. Während vieler Jahre 
blieb das B0-Transportsystem molekular unbekannt und war nur teilweise funktionell 
charakterisiert. Der erste B0-artige Transporter wurde von der Arbeitsgruppe Bröer im 
Jahr 2004 identifiziert. Dieser Transporter, B0AT1 („broad range amino acid tranporter 
1“), gehört der Mausgenfamilie Slc6 (human SLC6) der Na+-(und Cl-)-abhängigen 
(Neurotransmitter) Transporter an. Mittels Expression in Xenopus laevis Oozyten und 
nachfolgenden Flux- und elektrophysiologischen Messungen wurde gezeigt, dass es 
sich bei B0AT1 um einen Na+-abhängigen Cotransporter, der neutrale Aminosäuren 
transportiert, handelt. Anders als bei anderen Mitgliedern der Slc6-Familie und als für 
das System B0 erwartet, hängt dessen Funktion nicht von der Anwesenheit von Chlorid 
ab. Das orthologe, humane Gen SLC6A19 ist auf dem Chromosom 5p15.33 lokalisiert. 
Es konnte von uns, zusammen mit anderen Gruppen, gezeigt werden, dass ein Defekt 
in diesem Gen zur autosomal-rezessiven Hartnup Krankheit führt, welche durch eine 
erhöhte Ausscheidung von neutralen Aminosäuren im Urin charakterisiert ist. Diese 
Aminosäureausscheidung verläuft oft asymptomatisch, kann aber von einem „pellagra“-
ähnlichen Hautausschlag, zerebellaren Ataxie-Attacken und anderen neurologischen 
oder psychiatrischen Symptomen begleitet werden. 
Zwei ganz ähnliche humane Transporter, XT2 (Xtrp2) und XT3 (Xtrp3), wurden schon 
früher identifiziert und entsprechen den Genprodukten SLC6A18 und SLC6A20. 
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 Zusammen mit B0AT1 bilden diese einen separaten Cluster in der Familie SLC6. Eines 
dieser Gene, SLC6A18, ist gleich neben SLC6A19 auf dem Chromosom 5p15.33 
lokalisiert, während SLC6A20 auf Chromosom 3p21.3 zu finden ist. Im Mausgenom 
befinden sich zwei dem SLC6A20 verwandte Gene hintereinander auf  dem Chromosom 
9. Diese sind wahrscheinlich durch eine Duplikation entstanden, die nach der 
evolutionären Trennung von Nagern und Primaten stattgefunden hat. Das erste dieser in 
der Maus identifizierten Genprodukte wurde XT3 genannt. Das zweite Genprodukt, 
XT3s1, ist zu 90 % identisch mit dem XT3, ähnelt aber bezüglich der Primärstruktur und 
der Gewebeverteilung mehr dem humanen XT3. Beim Menschen existieren in Folge von 
alternativem Splicing des einzigen XT3-Gens zwei Isoformen. In 2005 wurde gezeigt, 
dass die eine dieser beiden humanen Isoformen sowie das murine XT3s1 dem Imino-
System angehören, das L-Pro sowie einige andere Substrate wie Pipecolate und N-
methylierte Aminosäuren (z. B. MeAIB und Sarcosin) mit einer hohen apparenten 
Affinität transportiert. Daher wurden diese Transporter in SIT1 oder IminoB umbenannt. 
Studien an den Orphantransportern XT2 und XT3 (Maus) ergaben, dass deren mRNAs 
in der Niere und möglicherweise im Dünndarm exprimiert werden. Die Expression von 
XT2 und Maus-XT3 in Xenopus laevis Oozyten und anderen Expressionssystemen 
führte zu keinem Ergebnis bezüglich der Funktion dieser Transporter. Eine kürzlich 
erschienene Studie an XT2 Knock-out-Mäusen ergab, dass diese Tiere Glycin und 
möglicherweise kleine Mengen anderer neutraler Aminosäuren im Urin ausscheiden, 
was nahe legen könnte, dass dieser Transporter, ähnlich dem B0AT1, neutrale 
Aminosäuren transportiert. 
Im ersten Teil meiner Doktorarbeit konzentrierte ich mich auf die Herstellung einer Kock-
out-Maus für XT3. Aufgrund verschiedener technischer Probleme wurde dieses Projekt 
nach wenigen Monaten beendet. 
Unser Interesse wandte sich in der Folge der Untersuchung der mutmasslichen Rolle 
dieser vier B0AT1-verwandten Genprodukte in der Maus zu. Wir lokalisierten die 
Expression dieser Gene einerseits mittels RT-PCR, wobei die mRNA-Mengen in 
verschiedenen Geweben quantitativ bestimmt wurden, und andererseits mittels Western 
Blot Analyse und Immunfluoreszenz, wobei die Expression der Proteine in Niere und 
Darm untersucht wurde. Im weiteren wurde untersucht, ob diese Transporter in der 
Niere unter gewissen Bedingungen auf der Stufe der mRNA bzw. des Proteins reguliert 
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 werden, indem C57BL/6J Mäuse einer natriumarmen bzw. -reichen Diät unterworfen 
oder in einer Weise behandelt wurden, dass eine metabolische Azidose bzw. Alkalose 
induziert wurde. Da die unterschiedlichen Behandlungen keinen Einfluss auf die 
Expression eines dieser Transporter hatte, schlossen wir daraus, dass diese im 
Wesentlichen eine konstitutive Rolle spielen. 
Die quantitative Real-time RT-PCR ergab, dass die mRNAs aller vier Mitglieder des 
B0AT-Clusters reichlich in der Niere vorkommen, während im Dünndarm nur diejenigen 
von B0AT1 und XT3s1/SIT1 erhöht waren. Im Gehirn war XT3s1/SIT1 mRNA reichlicher 
vorhanden als die übrigen mRNAs des B0AT-Clusters. Mit Hilfe der Immunfluoreszenz 
konnten wir nachweisen, dass alle vier Transporter des Maus B0AT-Clusters in der 
Bürstensaummembran des proximalen Nierentubulus exprimiert wurden, wobei die 
Expression der einzelnen Transporter in den Segmenten S1-3 entlang des Tubulus 
unterschiedlich war. Mit etwaiger Ausnahme von XT3 wurden die Transporter auch im 
Darm nachgewiesen. Deglykosylierungs-Experimente und Western Blot Analysen von 
Bürstensaummembran-Proteinen konnten die Glykosylierung der Transporter 
nachweisen sowie die luminale Lokalisierung von B0AT1, XT2 und XT3 bestätigen. 
Zusammenfassend lässt sich sagen, dass diese Arbeit sehr zur Charakterisierung der 
bisherigen Slc6 Orphantransporter des B0AT-Clusters beigetragen hat. Speziell die 
Lokalisierungsstudien haben die präzise Verteilung von B0AT1 und dessen verwandten 
Transportern in der Bürstensaummembran des proximalen Tubulus in der Niere und des 
Dünndarms verdeutlicht. Im weiteren zeigten diese Untersuchungen, dass die 
Transporter des B0AT-Clusters konstitutive Elemente von Aminosäure-reabsorbierenden 
Epithelien sind, nur moderaten regulatorischen Veränderungen unterliegen, und die 
Basis für die detaillierte in vivo Analyse des Maus-Transporters XT2 (Slc6a18) bilden. 
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INTRODUCTION 
 
1. General aspects of nutrition 
 
The survival of all living organisms strictly depend on a source of energy, required from 
cells to carry out all functions connected with life. Animals get their energy from 
ingestion of food, which is mainly constituted by proteins, carbohydrates and lipids.  To 
be used by the cells, these compounds, which are usually macromolecules, need to be 
cleaved into smaller molecules. Specific sets of enzymes in the mouth, stomach and 
intestine are responsible for cleavage of large molecules, in order to facilitate their entry 
in the cells.  
Inside the cells two types of chemical reactions occur: synthetic (anabolic) and 
breakdown (catabolic). Synthetic reactions are those in which molecules are linked 
together to form a more complex compound while breakdown reactions are those in 
which a complex compound is split into simpler molecules.  One important difference 
between them is that anabolic (synthetic) reactions generally require energy 
(endothermic), whereas catabolic reactions generally produce it (exothermic). In fact, 
one important function of catabolic reactions is to liberate energy. 
 
1.1 Protein metabolism 
 
A major component of food is protein. The proteins ingested as part of our diet are not 
the same proteins required by the body, nor can large molecules be absorbed from the 
gut. Therefore, these proteins are digested and their components, amino acids, di- and 
tripeptides, are absorbed into the blood stream. 
Proteins are the main constituent of nitrogen metabolism, which is as important as 
carbohydrate and lipid metabolism (Figure 1). Proteins make up the structural tissue for 
muscles and tendons, transport oxygen, haemoglobin, catalyze all biochemical reactions 
as enzymes, and regulate reactions as hormones. Our body must be able to synthesize 
the many proteins, amino acids, and other non-protein nitrogen containing compounds 
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 needed for growth, replacement, and repair. Proteins in excess are used to supply 
energy or build reserves of glucose, glycogen, or lipids. 
 
Figure 1. Amino acid metabolism. The scheme shows the fate of dietary proteins after 
their breakdown to single amino acid. For details, see the text. 
 
The "nitrogen or amino acid pool" is a grand mixture of amino acids available in the cell 
derived from dietary sources or the degradation of protein. Since proteins and amino 
acids are not stored in the body, there is a constant turnover, some proteins being 
synthesized while others degraded. For example, some liver and plasma proteins have a 
half-life of 180 days or more, while some enzymes and hormones may be recycled in a 
matter of minutes or hours. Each day, some amino acids are catabolized producing 
energy and ammonia. The ammonia is mostly converted to urea and excreted from the 
body and represents a drain on the nitrogen pool. A nitrogen balance is achieved by a 
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 healthy person when the dietary intake is balanced by the excretion, mostly as urea 
wastes. If nitrogen excretion is greater than the nitrogen content of the diet, the person is 
said to be in negative nitrogen balance. This is usually interpreted as an indication of 
tissue destruction. If the nitrogen excretion is less than the content of the diet, a positive 
nitrogen balance indicates a net formation of protein. 
Amino acids are divided into two classes depending on whether they can be synthesized 
in the human body (non-essential amino acids) or whether they must be supplied in the 
diet (essential) (Table 1).  
 
Non-essential amino acids Essential amino acids 
Alanine Tryptophan 
Asparagine Lysine 
Aspartate Methionine 
Cysteine Phenylalanine 
Glutamate Threonine 
Glutamine Valine 
Glycine Leucine 
Proline Isoleucine 
Serine Histidine (only in children) 
Tyrosine Arginine (only in children) 
 
Table 1. Essential and non-essential amino acids. The twenty classical proteogenic 
amino acids are divided in two classes depending on the ability of human beings to 
synthesize them. Two essential amino acids, histidine and arginine, are considered so 
only for children and not for adults. 
 
Non-essential amino acids are synthesized from the products of their catabolism - i.e. 
acetyl CoA, pyruvate or the relevant citric acid cycle intermediate. The amino group is 
donated by glutamate and added by  transamination reactions. 
Eight amino acids are generally regarded as essential for humans: tryptophan, lysine, 
methionine, phenylalanine, threonine, valine, leucine, isoleucine. Two others, histidine 
and arginine are essential only in children. 
9 
 The distinction between essential and non-essential amino acids is somewhat unclear, 
as some amino acids can be produced from others. The sulfur-containing amino acids, 
methionine and homocysteine, can be converted into each other but neither can be 
synthesized from scratch in humans. Likewise, cysteine can be only made from 
homocysteine. So, for convenience, sulfur-containing amino acids are sometimes 
considered a single pool of nutritionally-equivalent amino acids. Likewise, arginine, 
ornithine, and citrulline, which are interconvertible by the urea cycle, are considered a 
single pool. 
The essential amino acids are synthesized in microorganisms (bacteria and yeasts) and 
passed through the food chain until they reach us in our diet. One of the pathways 
essential to life that is carried out by bacteria is the "fixation" of atmospheric nitrogen 
initially as inorganic nitrate and ultimately as amino groups in amino acids. Higher 
organisms cannot perform this function. 
Amino acids are used in the body for synthesis of proteins, purines and pyrimidines 
(components of nucleotides), catecholamines (adrenaline and noradrenalin), 
neurotransmitters, histamine and porphyrins (the central oxygen binding component of 
haemoglobin). The synthesis of new proteins is very important during growth. In adults 
new protein synthesis is directed towards replacement of proteins as they are constantly 
turned over. Production of other components is also extremely important for nucleic 
acids synthesis, for interorgan communication, for central and peripherical nervous 
system activity and for many other processes. 
Moreover, amino acids are used as a biological fuel. About 10% of energy production in 
humans is from amino acids. The percentage is much higher in carnivores, whose diet 
contains much protein. 
 
2. Amino acid absorption in intestine 
 
2.1 The gastrointestinal tract 
 
The gastrointestinal tract consists of both the series of hollow organs stretching from the 
mouth to the anus and the several accessory glands and organs that add secretions to 
these hollow organs. Each of these organs, separated from each other at key locations 
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 by sphincters, has evolved to serve a specialized function. The mouth and oropharynx 
are responsible for chopping food into small pieces, lubricating it, initiating carbohydrate 
and fat digestion, and propelling the food into the esophagus. The esophagus acts as a 
conduit to the stomach, which temporarily stores food and initiates digestion by churning 
and by secreting proteases and acid. The small intestine continues the work of digestion 
and is the primary site for the absorption of nutrients. The large intestine reabsorbs fluids 
and electrolytes and stores the fecal matter before expulsion from the body. The 
accessory glands and organs include the salivary glands, pancreas and liver. The 
pancreas secretes digestive enzymes into the duodenum, in addition to secreting HCO3- 
to neutralize gastric acid. The liver secretes bile, which the gallbladder stores for future 
delivery to the duodenum during a meal. Bile contains bile acids, which play a key role in 
the digestion of fats. 
A cross section through a generic piece of stomach or intestine shows the characteristic 
layered structure of mucosa, submucosa, muscle and serosa (Figure 2A). 
The mucosa consists of the epithelial layer, as well as an underlying layer of loose 
connective tissue known as the lamina propria, which contains capillaries, enteric 
neurons, and immune cells (e.g. mast cells), as well as a thin layer of smooth muscle 
known as the lamina muscularis mucosae. The surface area of the epithelial layer is 
amplified by several mechanisms. Most cells have microvilli on their apical surfaces. In 
addition, the layer of epithelial cells can be evaginated to form villi or invaginated to form 
glands (or crypts) (Figure 2B). Finally, on a grosser scale, the mucosa is organized into 
large folds.  
The submucosa consists of loose connective tissue and larger blood vessels. The 
submucosa may also contain glands that secrete material into the GI lumen. 
The muscle layer, the muscularis externa, includes two layers of smooth muscle. The 
inner layer is circular whereas the outer layer is longitudinal. These muscles are 
responsible for peristalsis, which is a progressive wave of relaxation, followed by 
contraction. Enteric neurons are present between these two muscles layers. 
The serosa is an enveloping layer of connective tissue that is covered with squamous 
epithelial cells.  
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 2.2 Digestion of proteins 
 
Digestion involves the conversion of dietary food nutrients to a form that the small 
intestine can absorb. For carbohydrates and lipids, these digestive processes are 
initiated in the mouth by salivary and lingual enzymes: amylase for carbohydrates and 
lipase for lipids; protein digestion is initiated in the stomach by gastric proteases. 
Digestion is completed in the small intestine by the action of both pancreatic enzymes 
and enzymes at the brush border of the small intestine. Pancreatic enzymes, which 
include lipase, chymotrypsin and amylase, are critical for the digestion of lipids, proteins 
and carbohydrates respectively.  The enzymes on the luminal surface of the small 
intestine complete the digestion of carbohydrates and proteins. 
 
 
Figure 2. The small intestine. A. The drawing shows the different layers of intestinal 
wall. B. A drawing of a intestinal villus with its structure. The columnar epithelium is 
formed by enterocytes and goblet cells. For details see text. 
(http://www.bartleby.com/107/248.html). 
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Dietary proteins are a major component of food and they are usually ingested as large 
polypeptides, which are broken down to individual amino acids or short peptides before 
being absorbed into the blood stream. 
Large polypeptides ingested with the diet undergo a first cleavage in the stomach where 
hydrochloric acid denatures their structure exposing the peptide bonds to the digestive 
enzymes. Hydrochloric acid also converts the inactive form of the enzyme pepsinogen to 
its active form pepsin.  Pepsin cleaves proteins into smaller polypeptides and some 
amino acids.  The digestion of proteins continues in the small intestine, where proteolytic 
enzymes produced by the pancreas and activated such as trypsin, chymotrypsin, 
carboxypeptidases and others are released.  Trypsin cleaves peptide bonds next to the 
amino acids lysine and arginine.  Chymotrypsin cleaves peptide bonds next to the amino 
acids phenylalanine, tryptophan, tyrosine, methionine, asparagine, and histidine.  
Carboxypeptidases cleave amino acids from the acid (carboxyl) ends of polypeptides.  
Other proteases are for instance elastase and collaganase that cleave polypeptides into 
smaller polypeptides and tripeptides, aminopeptidases that cleave amino acids from the 
amino ends of small polypeptides (oligopeptides) and tripeptidases that cleave 
tripeptides to dipeptides and amino acids. 
 
2.3 Amino acid absorption 
 
The cells of the small intestine absorb amino acids and have peptidase enzymes on 
their surface that split most of the dipeptides and tripeptides into single amino acids. 
Amino acids are then co-transported into enterocytes with Na+, through a variety of 
specialized amino acid transporters, like heterodimeric transporter family (Dave et al., 
2004), ATB0 (Avissar et al., 2001; Kekuda et al., 1997), B0AT1 (Broer et al., 2004), the 
IMINO-system transporter SIT1 (Kowalczuk et al., 2005; Takanaga et al., 2005) and 
many others (Ganapathy, 1994; Ganapathy, 2001). Di- and tri-peptides and some amino 
acids are co-transported with H+ by members of the PEPT family (SLC15) (Ganapathy, 
1994; Ganapathy, 2001; Leibach and Ganapathy, 1996; Liang et al., 1995) and PAT1 
(SLC36) respectively (Anderson et al., 2004). 
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 Cells lining the intestinal mucosa are specialized polarized cells (Figure 3) (Madara and 
Trier, 1986). The distinct feature of these epithelial cells is the asymmetric distribution of 
macromolecules and organelles both in cytoplasm and in two plasma membrane 
domains (Achler et al., 1989; Drenckhahn and Dermietzel, 1988).  
 
Figure 3. Polarized cell. The drawing shows some features of polarized cells lining the 
intestinal mucosa and the proximal kidney tubule. The apical surface is kept distinct from 
the basolateral one by the presence of specialized junctions (tight junctions). 
(http://www.cytochemistry.net/Cell-biology) 
 
The polarized phenotype of the cell is mainly dependent on actin cytoskeleton, spectrin-
based membrane skeleton and microtubules (Burgess et al., 1987). Tight junctions also 
have a fundamental role during development of cell surface polarity, since they form an 
intramembrane diffusion fence that restricts diffusion of lipids in the plasma membrane. 
They form the limit between the apical and the basolateral membrane domain of the 
polarized epithelial cells that have distinct protein and lipid compositions. The apical 
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 membrane domain, facing the external milieu (lumen), is characterised by specialised 
structures such as microvilli (Mooseker, 1985; Mooseker et al., 1984). The presence of 
microvilli greatly increases the absorptive surface of these cells. 
Besides tight junctions, other junctional complexes such as adherent junctions and 
desmosomes are responsible for the maintenance of the structure of the epithelial 
monolayer and the polarity of the cells. 
 
3. Amino acid reabsorption in kidney 
 
3.1 Anatomy and physiology of the kidney 
 
The kidneys serve three essential functions. They function as filters, removing metabolic 
products and toxins from the blood and excreting them through the urine. They also play 
a key homeostatic role by regulating the body’s fluid status, electrolyte balance, and 
acid-base balance. Finally, kidneys produce hormones involved in erythrogenesis, 
calcium metabolism and regulation of blood pressure and blood flow.  The mammalian 
kidneys perform certain functions that in lower vertebrates are shared by other organs 
such as the skin and bladder of amphibians, the gills of fishes and the salt glands of 
reptiles and birds. 
Mammalian kidneys are paired, bean-shaped structures, one located on each side 
against the dorsal inner surface of the lower back, outside the peritoneum. The kidneys 
receive a remarkably large blood flow (20-25% of the total cardiac output at rest) 
corresponding thus to the total blood volume every 4-5 minutes. 
The outer functional layer, the cortex, is covered by a tough capsule of connective 
tissue. The inner functional layer, the medulla, sends papillae projecting into the renal 
pelvis that gives rise to the ureters, which empty into the urinary bladder. 
Urine contains water and other by-products of metabolism, such as urea as well as other 
solutes, like NaCl, KCl, phosphates and others that are present at concentrations in 
excess of the body’s requirement. 
The functional unit of the mammalian kidney is the nephron, an intricate epithelial tube 
that is closed at its beginning but open at its distal end. Each kidney contains around 
one million nephrons (in human), which empty into collecting ducts. These ducts 
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 combine to form papillary ducts, which eventually empty into renal pelvis. At the closed 
end, the nephron is expanded to form a cup-shaped Bowman’s capsule. The lumen of 
the capsule is continuous with the narrow lumen that extends through the renal tubule. A 
tuft of capillaries forms the renal glomerulus inside Bowman’s capsule. This remarkable 
structure is responsible for the first step in urine formation. An ultrafiltrate of the blood 
passes through the single-cell layer of the capillary walls, through a basement 
membrane, and finally through another single-cell layer of epithelium that forms the wall 
of Bowman’s capsule. The ultrafiltrate accumulates in the lumen of the capsule to begin 
its trip through the various segments of the renal tubule, finally descending the collecting 
duct and eventually into the renal pelvis. 
The wall of the renal tubule is one cell layer thick; this epithelium separates the lumen, 
which contains the ultrafiltrate, from the interstitial fluid. In some portions of the nephron, 
the epithelial cells are morphologically specialized for transport, bearing a dense pile of 
microvilli on their luminal, or apical, surfaces and deep infolding of their baso-lateral 
membrane. The epithelial cells of the proximal tubule are tied together by leaky tight 
junctions, which permit limited paracellular diffusion between the lumen and interstitial 
space surrounding the renal tubule. 
The nephron can be divided into three main regions: the proximal nephron (Bowman’s 
capsule and proximal tubule), the loop of Henle (with a descending limb and an 
ascending limb) and the distal nephron (after the ascending limb of the loop of Henle 
merges into the distal tubule). Distal tubules from many nephrons merge into a unique 
collecting duct. 
The number of nephrons per kidney varies from several hundred in lower vertebrates to 
many thousands in small mammals, and a million or more in humans and other large 
species. 
The loop of Henle, found only in the kidneys of birds and mammals, is considered to be 
of central importance in concentrating the urine. Vertebrates lacking the loop of Henle 
are incapable of producing urine that is hyperosmotic to the blood. 
In mammals, the nephron is so oriented that the loop of Henle and the collecting duct lie 
parallel to each other. The glomeruli are found in the renal cortex, and the loops of 
Henle reach down into the papillae of the medulla; thus, the nephrons are arranged in a 
radiating fashion within the kidney. 
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 Nephrons can be divided into two groups: 
- juxtamedullary nephrons, which have their glomeruli in the inner part of the cortex 
and long loops of Henle that plunge deeply into the medulla; 
- cortical nephrons, which have their glomeruli in the outer cortex and relatively 
short loops of Henle that extend only a short distance into the medulla. 
The final urine composition is the result of three main processes: 
- glomerular filtration of plasma to form an ultrafiltrate in the lumen of the 
Bowman’s capsule; 
- tubular reabsorption of approximately 99% of the water and most of the salts from 
the ultrafiltrate leaving behind and concentrating waste products such as urea; 
- tubular secretion of a number of substances via active transport in nearly all 
instances. 
 
3.2 The Proximal tubule 
 
Based on its appearance at relatively low magnification, the proximal tubule can be 
divided into a convoluted part, the proximal convoluted tubule and a straight part, the 
proximal straight tubule. However, based on ultrastructure, the proximal tubule can 
alternatively be subdivided into three segments: S1, S2 and S3. The S1 segment starts 
at the glomerulus and includes the first portion of the proximal convoluted tubule. The S2 
segment starts within the second half of the proximal convoluted tubule and continues 
into the first half of the proximal straight tubule. Finally, the S3 segment includes the 
distal half of the proximal straight tubule that extends into the medulla. 
Both the apical (luminal) and the basolateral (peritubular) membranes of proximal-tubule 
cells are extensively amplified. Therefore, the apical membrane shows infolding in the 
form of a well-developed brush border system (Figure 3). This enlargement of the apical 
surface area correlates with the main function of this nephron segment, namely, the 
reabsorption of the bulk of the filtered fluid back into the circulation. From the S1 to the 
S3 segments, cell complexity progressively declines, correlating with a gradual decrease 
of reabsorptive rates along the tubule, thus, the cells exhibit a progressively less 
developed brush border system, diminished complexity of lateral cell interdigitations, a 
lower basolateral cell membrane area and a decrease in the number of mitochondria. 
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 The basolateral membranes of adjacent proximal-tubule cells form numerous 
interdigitations, bringing abundant mitochondria in close contact with the plasma 
membrane. The interdigitations of the lateral membranes also form an extensive 
extracellular compartment bounded by the tight junctions at one end, and by the 
basement membrane of the epithelium at the other end. Proximal-tubule cells contain 
lysosomes, endocytic vacuoles, and a well-developed system of endoplasmic reticulum. 
Proximal-tubule cells are also characterized by a prominent Golgi apparatus, which is 
important for synthesizing many membrane components, sorting them and targeting 
them to specific surface sites. 
 
3.3 Amino acid reabsorption 
 
Amino acids released in the blood stream are reabsorbed by the proximal-tubule cells. 
Specific amino acid transporters, like in the small intestine, are localized in the brush 
border structure present at the apical site of these cells where they take up their 
substrates that are dissolved in the ultrafiltrate. 
The amino acid transport machinery is not uniform along the proximal tubule; just after 
glomerular filtration occurs, the amino acid concentration in the ultrafiltrate is similar to 
that found in plasma, whereas at the end of the proximal tubule it is lower. Thus, while 
the first epithelial cells of the proximal tubule face a high solute concentration, more 
distal epithelial cells face decreasing substrate concentrations that can more effectively 
be reabsorbed by transporters with high affinity. 
 
4. Amino acid transporters 
 
4.1 General aspects 
 
Amino acid transporters are macromolecules synthesized by all cell types in order to 
move such solutes across the cell membranes. They usually display a tertiary structure 
with membrane spanning segments that have important functions in the transport 
mechanism.  These segments are mainly constituted by α-helices, which are particularly 
suitable to cross the lipid bilayer. 
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 In kidney proximal tubule and small intestine, specialized amino acid transporters are 
localized to either one of the two specialized membranes, the apical (luminal) membrane 
or the basolateral one. Transporters at the apical membrane allow the passage of 
specific amino acids from the extracellular medium to the cell cytoplasm while the ones 
localized at the basolateral membrane are responsible for moving amino acids from the 
cell into the blood stream. This active transport process is referred as the transcellular 
pathway, which differs from the paracellular one where the substances do not cross the 
cell but pass between adjacent cells. In polarized epithelia, like the ones found in the 
small intestine and in the proximal tubule, the apico-basal polarity is important for the 
establishment of adhesive junctions and the formation of a paracellular diffusion barrier 
that prevents the movement of solutes across the epithelium (Gibson and Perrimon, 
2003).  
Once in the blood, amino acids are distributed throughout the body: they are taken up by 
tissues (particularly by the liver and the muscle) and they pass through the blood-brain 
barrier to enter the central nervous system (Smith, 2000; Stoll et al., 1993). In the 
placenta, amino acids pass through the placental barrier in both directions between the 
maternal and the foetus sides (Cariappa et al., 2003).  
Amino acid transporters are also present in the membranes of some intracellular 
organelles, such as lysosomes and mitochondria (Boll et al., 2004; Porter, 2000). 
 
4.2 Amino acid transport systems 
 
The study of amino acid transport into animal cells actually began in 1914 with the 
observations of Van Slyke and Meyer who demonstrated tissue accumulation of amino 
acids against a concentration gradient. Description of individual transport activities 
began in the early 1960s with the pioneering work of Christensen ‘s laboratory (Oxender 
and Christensen, 1963). They described transport systems with different specificity for 
amino acids in mammalian cells (mainly erythrocytes, hepatocytes, and fibroblasts) 
(Christensen, 1990), and identified general properties of mammalian amino acid 
transporters: stereospecificity (transport selectivity for L-stereoisomers) and broad 
substrate specificity (several amino acids share a transport system). Since these initial 
studies, the main functional criteria used to define amino acid transporters have been 
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 the type of amino acid transported (acidic, zwitterionic, or basic as well as other 
characteristics of the side chain), the precise substrate specificity, the kinetic properties, 
and the thermodynamic properties (equilibrative or uphill transport). This functional 
classification has been retained to date, since structural information on higher eukaryote 
amino acid transporters is incomplete (Broer, 2002; Palacin et al., 1998; Verrey et al., 
2005). Another classification, involving all types of proteins (excluding pumps and 
channels) moving solutes from one side of a biological membrane to another (solute 
carriers, SLC), has been recently developed by the HUGO (the Human Genome 
Organization) Gene Nomenclature Committee. The new nomenclature has been 
introduced in order to uniform the names of proteins belonging to the SLC series (the 
complete list is available on the web site: http://www.gene.ucl.ac.uk/nomenclature/). 
There are 43 SLC families with overall more than 320 transporter genes (Wright M. W. 
et al., 2003). Out of these families, 9 are dedicated to or contain members that perform 
amino acid transport (Figure 4) (Boll et al., 2004; Chen et al., 2004; Gasnier, 2004; 
Halestrap and Meredith, 2004; Hediger et al., 2004; Kanai and Hediger, 2004; 
Mackenzie and Erickson, 2004; Palacin and Kanai, 2004; Verrey et al., 2004). 
The original nomenclature introduced by Christensen was based on the first 
observations collected with functional studies in isolated cells and plasma membranes of 
perfused organs. Focus of these investigations was the substrate specificity, the 
kinetics, the driving forces and the different regulatory mechanisms which led to the 
identification of different transport systems for amino acids in mammalian plasma 
membranes (Christensen, 1985; Christensen, 1989).  In most of the cases, the name of 
the transporter has one or more letters, which identify the specific amino acid transporter 
or the class of amino acids and, in general, a capital letter indicates Na+ dependence, 
whereas a small letter Na+ independence. This classification has been adopted 
previously for so called transport systems before the transporters had been molecularly 
identified.  
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Figure 4. Mammalian amino acid transporter families. The arrows indicate the co-
/counter-transport. Dashed arrows indicate that only some of the members of the family 
transport that substance. Slide courtesy of F. Verrey. 
 
4.3 The SLC6 family 
 
The SLC6 family comprises transporters that mediate solute translocation across cell 
plasma membranes by coupling solute transport to the cotransport of sodium down its 
electrochemical gradient. Some transporters cotransport chloride as well. The family 
includes transporters for the inhibitory neurotransmitters GABA and glycine, for the 
monoamine transmitters norepinephrine, serotonin, and dopamine, for the osmolytes 
betaine and taurine, the amino acid proline, and the metabolic compound creatine. In 
addition, this family includes a system B0+ cationic and neutral amino acid transporter, a 
B0-system transporter, an IMINO-system transporter, and four transporters for which the 
solutes are unknown (Figure 5). In general, SLC6 transporters act to regulate the level of 
extracellular solute concentrations. In the central and the peripheral nervous system, the 
neurotransmitter reuptake transporters modulate signaling among neurons. They thus 
represent sites of action of various drugs and drugs of abuse. Furthermore, naturally 
occurring mutations in several of these proteins are associated with a variety of 
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 neurological disorders. In kidney and small intestine, the amino acid transporters of this 
family mediate the luminal step of the (re)-absorption of diverse amino acids. 
 
 
Figure 5. Phylogenetic tree of mouse Slc6 family. Protein sequences of the mouse 
Slc6 family members were aligned and a phylogenetic tree constucted. Accession 
numbers are: serotonin transporter (5HTT), Q60857; noradrenaline transporter, O55192; 
dopamine transporter, NP_034150 ; GABA transporter 1 (GAT1), NP_848818; creatine 
transporter (CT1), NP_598748; taurine transporter (TauT), NP_033346; GABA/betaine 
transporter (GAT2), P31651; GABA transporter 4 (Gabt4), P31650; GABA transporter 3 
(GAT3), P31649; proline transporter (ProT), XP_140385; glycine transporter 1 (GlyT1) 
NP_032161; glycine transporter 2 (GlyT2) NP_683733; amino acid transporter B0,+ 
(ATB0,+), AAK43541; orphan transporter (NTT73), NP_780537; orphan transporter 
(NTT4), NP_758475; orphan transporter (XT3), NP_035861; amino acid transporter 
(B0AT1), XP_127449; and orphan transporter (XT2, isoformA12), AAC27757; X 
transporter protein 3 similar 1 (XT3s1/SIT1), NP_631881. 
 
The SLC6 transporters have an approximate length of 600 amino acids with 12 
transmembrane segments and cytoplasmic NH2- and COOH-terminal tails (Lill and 
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 Nelson, 1998; Nelson, 1998; Yamashita et al., 2005). A large, extracellular loop, with 
glycosylation sites, is present between TM 3 and 4. Recent evidence suggests that at 
least some of these transporters function in homo-oligomeric form (Hastrup et al., 2001; 
Kilic and Rudnick, 2000; Schmid et al., 2001; Sorkina et al., 2003; Torres et al., 2003). 
The driving forces for the transport of substrates (neurotransmitter or amino acid) 
against their concentration gradient are provided by the electrochemical gradient for the 
cotransported Na+. Cl– is also co-transported by many members of this family. In 
addition, one member (the serotonin transporter SERT encoded by SLC6A4), requires 
the counter-transport of K+ (Rudnick and Clark, 1993). The role of Cl– in the transport 
process is not well understood. It is unlikely to provide an electrical driving force for 
transport since the resting membrane potential of many cells is near the Cl– equilibrium 
potential; rather, it may play a role in enhancing Na+ binding affinity and providing 
chemical driving force particularly necessary in excitable cells (Bossi et al., 2002; Loo et 
al., 2000). The domains that subserve substrate binding and the residues that form the 
permeation path are presently active areas of investigation. Some transporters show ion 
fluxes that exist in addition to stoichiometrically coupled uptake, while several show ion 
conductances in the absence of transmitter (Beckman and Quick, 1998).  
A recent publication from Gouaux’s group gives some insights on the possible structure 
of Na+/Cl- -dependent transporters and on the functional residues which could be 
involved in the binding of the substrate. They presented the crystal structure of a 
bacterial homologue of Na+/Cl- -dependent transporters (LeuTAa) from the bacterium 
Aquifex aeolicus, in complex with its substrate, leucine, and two sodium ions (Yamashita 
et al., 2005).  This protein has 12 transmembrane helical regions (TM1 to TM12), 
together with numerous loops and helices on the intracellular and extracellular surfaces.  
It shows an unanticipated internal structural repeat in the first ten transmembrane 
helices, relating TM1–TM5 and TM6–TM10 by a pseudo-two-fold axis located in the 
plane of the membrane. The most striking feature is that TM1 and TM6 have breaks in 
their helical structure at positions approximately halfway across the membrane bilayer. 
Gouaux’s group showed that in these regions the substrate (Leu) and the two Na+ are 
bound during the transport cycle. Moreover, from the crystal structure data, there are 
other helical and loop segments on the solvent exposed surfaces of LeuTAa, which are 
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 situated in regions that suggest a role in the transport mechanism (Yamashita et al., 
2005). 
4.3.1 System B0 
Most neutral amino acids are transported by system B0, which was firstly described in 
the early ‘70s (Evers et al., 1976; Murer et al., 1976; Palacin et al., 1998; Sigrist-Nelson 
et al., 1975).  In the last 30 years, system B0 has been characterized in jejunal brush 
border vesicles (Munck and Munck, 1994; Stevens et al., 1982), bovine epithelial cells 
(Doyle and McGivan, 1992), and Caco-2 cells (Souba et al., 1992). These studies 
suggest that system B0 is a Na+-dependent, chloride-independent transporter that 
accepts a wide variety of neutral amino acids. Failures to reabsorb amino acids in the 
kidney and intestine underlie a number of inherited transporter diseases, with mutations 
in either rBAT or b0,+AT causing cystinuria (Palacin et al., 2000), mutations of the IMINO 
system believed to cause iminoglycinuria (Chesney, 2001) and mutations of system B0 
thought to cause Hartnup disorder (Levy, 2001).  
A phylogenetic analysis of mouse SLC6 family shows that four amino acid transporters, 
B0AT1, XT2, XT3 and XT3s1/SIT1 form a separate cluster (Verrey et al., 2005) (Figure 
5). They share high sequence similarity (Table 2) and they are all expressed in kidney 
and small intestine epithelia (See Results section).  
 
Sequence A 
Length 
(aa) 
Sequence B 
(comparison) 
Length 
(aa) 
Sequence 
identity (%) 
B0AT1 (Slc6a19) 634 XT3 (Xtrp3) 635 43 
B0AT1 (Slc6a19) 634 XT2 (Slc6a18) 615 52 
B0AT1 (Slc6a19) 634 XT3s1/SIT1 (Slc6a20) 592 46 
XT3 (Xtrp3) 635 XT2 (Slc6a18) 615 45 
XT3 (Xtrp3) 635 XT3s1/SIT1 (Slc6a20) 592 90 
XT2 (Slc6a18) 615 XT3s1/SIT1 (Slc6a20) 592 46 
 
Table 2. Amino acid sequence comparison. The four mouse Slc6 proteins have been 
compared using ClustalW multiple sequence alignment program 
(http://www.ebi.ac.uk/clustalw/). 
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 4.3.1.1 B0AT1 (Slc6a19) 
Unlike other transporters that were molecularly identified several years ago, no 
transporter corresponding to system B0 was identified before 2004, when Broer and 
colleagues cloned and functionally characterized the first mouse B0-type transporter  
(Broer et al., 2004).  This transporter was named B0AT1 (Slc6a19). 
Heterologous expression of B0AT1 cDNA in Xenopus laevis oocytes induced a Na+-
dependent, Cl--independent uptake of neutral amino acids with an apparent affinity for L-
leucine uptake in the order of magnitude previously measured in other systems (Bohmer 
et al., 2005; Broer et al., 2004; Camargo et al., 2005; Camargo SMR et al., 2005; 
Samarzija and Fromter, 1982; Stevens et al., 1982).  
Mutations of system B0 were long thought to cause Hartnup disorder (MIM 234500 
OMIM), an autosomal recessive disorder resulting from impaired neutral amino acid 
transport, largely limited to the kidneys and the small intestine. Its diagnostic hallmark is 
a striking neutral hyperaminoaciduria (Baron et al., 1956; Levy, 2001). A number of 
additional symptoms have been reported in Hartnup disorder patients, including 
photosensitive skin rash, ataxia, and psychotic behaviour (Baron et al., 1956; Levy, 
2001). Nevertheless, many of those affected remain asymptomatic despite the 
hyperaminoaciduria. This variation in manifestations of Hartnup disorder may be a 
consequence of compensation for the reduced amino acid transport by increased 
peptide transport in the intestine or the presence of genetic or environmental modifiers, 
such as dietary variations. Despite its apparently mild phenotype, Hartnup disorder has 
been a model disease, because it illustrates the principles of amino acid reabsorption in 
epithelial cells. Homozygosity mapping in consanguineous families has recently 
localized the disorder to chromosome 5p15 (Nozaki et al., 2001). 
The hypothesis that homozygote mutations of the corresponding gene leads to Hartnup 
disorder was verified in a large fraction of the tested cases, including in the original 
Hartnup family (Broer et al., 2005; Kleta et al., 2004; Seow et al., 2004). The question 
remains as to whether the cases of Hartnup disorder that do not map to SLC6A19 are 
from mutations in other transporters or from defects in another gene product necessary 
for the correct expression and/or function of B0AT1 (Kleta et al., 2004). 
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 4.3.1.2 XT2 (Slc6a18) 
The first report about XT2 (Slc6a18) and XT3 (Xtrp3) is from Nash and colleagues (Nash 
et al., 1998). The cDNAs of  mouse XT2 they obtained showed the existence of six 
splice variants. Among these, the A12 isoform is the closest to human XT2 (SLC6A18) 
and to the orthologue in rat, ROSIT (Obermuller et al., 1997; Wasserman et al., 1994). 
The chromosomal location of the gene for XT2 in the mouse was shown to be on 
chromosome 13, within a large linkage group conserved with human chromosome 5 
(Justice and Stephenson, 1994). 
The expression of these isoforms in heterologous systems in transfected cells and 
oocyte expression systems failed to determine conclusive substrate specificity (Nash et 
al., 1998; Quan et al., 2004).  
Wasserman’s group reported in 1994 that ROSIT (renal osmotic stress induced Na+,Cl-- 
organic solute cotransporter) mRNA is expressed in the renal cortex and outer medulla 
(Wasserman et al., 1994). It was also shown that hypernatremia caused a large increase 
in the expression of ROSIT mRNA in renal cortex, outer medulla, and possibly small 
intestine, suggesting that the substrate that is transported may serve as an organic 
osmolyte or osmolyte precursor for the body. The distribution of ROSIT mRNA is unique 
and is different from that of taurine and betaine and Na+/myoinositol transporters. 
Uptake studies using Xenopus laevis oocytes expressing ROSIT were all negative, 
suggesting that ROSIT is not involved in the transport of neurotransmitters, amino acids, 
or the major organic osmolytes (Wasserman et al., 1994). Very recently, the group of 
Tomita examined the intranephron localization and regulation of ROSIT mRNA 
expression using microdissected nephron segments from control and dehydrated rats 
(Baba et al., 2004). The results showed that ROSIT mRNA expression was stimulated in 
whole nephron segments by dehydration. ROSIT mRNA expression in kidney proximal 
tubule was stimulated by hypertonicity, but not urea. The failure of urea with the same 
osmolarity to stimulating ROSIT mRNA expression could be explained by a low osmotic 
effect of urea due to its high permeability or by the inhibitory effect of urea on metabolic 
pathways. This report suggested that ROSIT might participate in the transport of amino 
acids in the control conditions and that of organics osmolytes in dehydration.  
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 Finally, a study in post-ischemic rat kidney showed that renal osmotic stress-induced 
cotransporter mRNA levels were already decreased eight hours post-ischemia. At seven 
days post-ischemia, ROSIT mRNA reappeared in a mosaic pattern in the regenerating 
S3 segment, being fully expressed three weeks after the insult except for focal areas 
(Obermuller et al., 1997).  
Recently, Caron’s group generated a XT2-knockout mouse. In screening urine from 
XT2-knockout mice by high-pressure liquid chromatography and mass spectrometry, 
they found a significantly elevated concentration of glycine. To study glycine handling, 
XT2+/+ and XT2–/– mice were injected with radiolabeled glycine, and urine samples were 
collected to monitor glycine excretion. After 2 h, XT2–/– mice were found to excrete 
almost twice as much glycine as the XT2+/+ controls (P = 0.03). To determine whether 
the absence of the XT2 transporter affected sodium and fluid homeostasis, they 
measured systolic blood pressure by computerized tail-cuff manometry. Systolic blood 
pressure was significantly higher in XT2–/– mice (127 ± 3 mmHg) than in wild-type 
controls (114 ± 2 mmHg; P < 0.001). This difference in systolic blood pressure was 
maintained on high and low salt feeding. To examine whether the alteration in blood 
pressure and the defect in glycine handling were related, systolic blood pressure was 
measured in the XT2–/– mice during dietary glycine supplementation. Glycine loading 
caused systolic blood pressure to fall in the XT2–/– mice from 127 ± 3 to 115 ± 3 mmHg 
(P < 0.001), a level virtually identical to that of the wild-type controls. These data suggest 
that the XT2 orphan transporter is involved in glycine reabsorption and that the absence 
of this transporter is sufficient to cause hypertension (Quan et al., 2004). 
 
4.3.1.3 XT3 (Xtrp3) 
XT3 gene in human is localized on chromosome 3. Kiss and co-workers, characterizing 
this mRNA in 2001, discovered a differently spliced form of the mRNA in brain, 
designated XT3a. Primers used for the amplification of XT3 from the brain cDNA library 
produced two bands observed on the agarose gel. The sequence of the shorter band 
indicated that exon 5 is alternatively spliced and is not present in the XT3a splice form 
(Kiss et al., 2001). The brain-specific isoform is predicted to lack one of the 12 putative 
transmembrane domains, whereas the isoform expressed in kidney has an overall 
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 domain structure similar to B0AT1 (Kiss et al., 2001). The longer splice form is 592 
amino acids long while the shorter one (XT3a) has only 555 amino acids. 
In mouse, two separate genes exist adjacent one another on chromosome 9, XT3 and 
XT3s1, 635 and 592 amino acids long, respectively. They are 90% identical and XT3s1 
shows higher similarity to the human XT3 and to the rat rB21A compared with the 
mouse XT3. Therefore, it has been suggested that the mouse XT3s1 gene is the 
orthologue of the human XT3, whereas mouse XT3 is a new product of XT3s1 
duplication (Kiss et al., 2002).  
Mouse XT3s1 and human XT3 have recently been functionally characterized and 
renamed SIT1 (Sodium/Imino-acid Transporter 1) (see next paragraph) (Kowalczuk et 
al., 2005; Takanaga et al., 2005). The function of mouse XT3 remains unknown.  
Screening experiments to identify the substrate(s) of mouse XT3 failed to identify 
specific uptake with any of the tested compounds (all 20 amino acids, osmolytes and 
neurotransmitters); however, immunofluorescence microscopy demonstrated that 
epitope-tagged variants of the protein products of the XT3 cDNAs were present on the 
plasma membrane of transfected cells (Nash et al., 1998). 
Our group also tried to characterize the function of mouse XT3 but without success. 
Immunofluorescence analysis of Xenopus laevis oocytes injected with mXT3 cRNA 
showed no surface expression. Similar results were obtained when mXT3 was 
transfected in Madin-Darby canine kidney (MDCK), Murine Principal Kidney Cortical 
Collecting Duct (mpkCCD) or Human Embryonic Kidney 293 (HEK293) cell lines (Ristic, 
unpublished results).  Apical staining was observed only when mXT3 was transfected in 
Opossum kidney (OK) cells but no specific function could be detected upon radiolabelled 
amino acids exposure (Ristic and Romeo, unpublished data). 
4.3.2 System IMINO 
The transport of proline has been studied extensively in epithelial cells from kidney and 
intestine (Munck and Munck, 1995; Silbernagl et al., 1975; Stevens et al., 1984).The 
amino acid is completely reabsorbed in the proximal tubule of the kidney and also 
efficiently absorbed in the intestine. Several routes have been described for the 
epithelial transport of proline: first a specific Na+-dependent transporter for proline and 
hydroxyproline, called the IMINO system (Stevens and Wright, 1985; Stevens and 
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 Wright, 1987), secondly a transporter shared by proline and glycine and some other 
amino acids, such as GABA (γ-aminobutyric acid) and β-alanine, which has been termed 
the ‘imino acid carrier’ (Munck et al., 1994; Roigaard-Petersen et al., 1987), and, thirdly, 
the Na+-dependent neutral-amino-acid-transport system, B0 (Ganapathy et al., 1983). 
Depending on the tissue and species, either the IMINO system or the imino acid carrier 
may carry the main load of proline transport in epithelia (Munck and Munck, 1994). The 
molecular correlate of the imino acid carrier is the proton/amino acid transporter PAT1 
(Anderson et al., 2004). System B0 is encoded by B0AT1 gene (Broer et al., 2004), but 
the molecular identity of the IMINO system has remained elusive until very recently 
(Takanaga et al., 2005). 
The IMINO system has been characterized in some detail in vesicles from rabbit jejunum 
(Munck and Munck, 1994; Stevens and Wright, 1985; Stevens and Wright, 1985; 
Stevens and Wright, 1987). These studies indicate that proline is co-transported with 
Na+ and Cl- ions with a stoichiometry of 1:2:1. Na+ ions are thought to bind to the 
transporter before the substrate does. At physiological Na+ concentrations, the Km for 
proline is about 0.3 mM. Proline is the only proteinogenic amino acid accepted by the 
IMINO system. Additional substrates are L-pipecolate, hydroxyproline, proline methyl 
ester, betaine and MeAIB (N-methylaminoisobutyric acid). The transporter is 
stereoselective, preferring L-proline over D-proline (Stevens and Wright, 1985). 
4.3.2.1 XT3s1/SIT1 (Slc6a20) 
As mentioned previously, very recently two independent groups cloned and 
characterized XT3s1/SIT1 from mouse, human and rat and showed that it corresponds 
to system IMINO (Kowalczuk et al., 2005; Takanaga et al., 2005), renaming it SIT1.  
Takanaga and colleagues showed that rat SIT1 expressed in Xenopus laevis mediates 
the uptake of imino acids such as proline and pipecolate, as well as N-methylated amino 
acids (e.g. MeAIB, sarcosine). SIT1-mediated proline transport was shown to be pH-
independent and insensitive to inhibition by alanine or lysine. Proline transport was Na+-
dependent, Cl--stimulated, and voltage-dependent. Li+, but not H+, could substitute for 
Na+. Human SIT1 also functioned as a Na+-dependent proline transporter. Rat SIT1 
mRNA was expressed in epithelial cells of duodenum, jejunum, ileum, stomach, 
caecum, colon, and kidney proximal tubule S3 segment. SIT1 mRNA was also 
29 
 expressed in the choroid plexus, microglia, and meninges of the brain and in the ovary 
(Takanaga et al., 2005). Kowalczuk and colleagues took into consideration both mouse 
gene products, mXT3 and mXT3s1/SIT1. They demonstrated that expression of mouse 
XT3s1, but not XT3, in Xenopus laevis oocytes induced an electrogenic Na+-and-Cl--
dependent transport for proline, hydroxyproline, betaine, N-methylaminoisobutyric acid 
and pipecolic acid. Expression of XT3s1 was found in brain, kidney, small intestine, 
thymus, spleen and lung, whereas XT3 prevailed in kidney and lung. They also 
proposed that the two homologues could be termed 'XT3s1 IMINO(B)' and 'XT3 
IMINO(K)' to indicate their tissue expression (Kowalczuk et al., 2005). 
 
5. In vivo and in vitro models for amino acid transporter studies 
 
5.1 In vivo models: knockout mice 
 
Renal transport of amino acids was originally investigated in intact animals by measuring 
their urinary excretion and with microperfusion experiments using tracer flux 
measurements, as well as electrophysiological recordings (Evers et al., 1976; Fass et 
al., 1977; Sigrist-Nelson et al., 1975). 
The possibility to easily produce genetically modified mice, precisely targeting the gene 
of interest, allows the investigation of the resulting phenotype using methods as those 
mentioned above. Knockout mice exist for many transport proteins. For example, the 
analysis of GlyT knockout mice has revealed distinct functions of individual GlyT 
subtypes in synaptic transmission and provided animal models for two hereditary human 
diseases, glycine encephalopathy and hyperekplexia.  These studies suggested that 
selective GlyT inhibitors could be of therapeutic value in cognitive disorders, 
schizophrenia and pain (Eulenburg et al., 2005).   
Another example is the Slc7a9 knockout mouse providing a model to investigate in vivo 
the role of b0,+AT in cystinuria. Expression of b0,+AT protein is completely abolished in 
the kidney of Slc7a9-/- mice which present a dramatic hyperexcretion of cystine and 
dibasic amino acids, while Slc7a9+/- mice show moderate but significant hyperexcretion 
of these amino acids (phenotype non-I). Forty-two per cent of the knockout mice develop 
cystine calculi in the urinary system. Histopathology in kidney reveals typical changes for 
urolithiasis (tubular and pelvic dilatation, tubular necrosis, tubular hyaline droplets and 
30 
 chronic interstitial nephritis). Thus, Slc7a9 knockout mice provide a valid model of 
cystinuria which can be used in the study of genetic, pharmacological and environmental 
factors involved in cystine urolithiasis (Feliubadalo et al., 2003). 
Another model is the Slc6a18 (XT2) knockout mouse described previously (Quan et al., 
2004). 
Thanks to the high homology with humans, mice are good models for investigation of 
human diseases. In this sense, the major advantage is the possibility to analyse the 
phenotype of mutant organisms. This involves the major technical and conceptual 
difficulty represented by the expression of different transport systems with overlapping 
substrate specificity.  
 
5.2 Studies on differentiated cells in culture 
 
Other studies of amino acid transport have been performed on cultured epithelial cells 
(primary cultures and immortalized cell lines). Epithelial cells, as those from the renal 
proximal tubule and the small intestinal villus, are characterized by the fact that they 
have distinct plasma membrane domains: an apical and a basolateral one. The ability of 
epithelial cells to mediate vectorial transport of ions and solutes against their 
concentration gradients depends on the asymmetrical distribution of transporters at the 
cellular surface.  
Established cell lines of renal origin are frequently used for analyzing renal transport 
function. One disadvantage of every study with an established cell line, however, is the 
relative dedifferentiation compared to te cells of origin and the fact that the initial genetic 
homogeneity could be lost at higher passage numbers due to spontaneous mutations. 
Several cultured epithelial cell lines of renal origin are known to express amino acid 
uptake across the apical and/or basolateral membrane: LLCPK1 (ATCC CRL 1392) 
(Rabito and Karish, 1982; Rabito and Karish, 1983), MDCK (Boerner and Saier, 1985), 
HEK-293 (ATCC CRL 1573), OK (ATCC CRL 1840) cells etc. The cell line that has been 
extensively used as a model for proximal tubule transport to date is the OK cell line. The 
proximal tubule derived opossum kidney, OK cell line expresses a quite complete set of 
amino acid transporters known to be involved in the vectorial trans-epithelial flux of 
amino acids. For instance, OK cells express rBAT-associated system b0,+ exchange 
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 activity in the apical pole (Mora et al., 1996), the basolateral system L isoform 
LAT2/4F2hc and the basolateral system y+L (most probably y+LAT/4F2hc transporter) 
(Fernandez et al., 2003). Recently, in our laboratories, some studies on XT3 were 
carried out in OK cells using antisense RNA or siRNA to “knock down”  the specific 
transporter allowing to demonstrate the contribution of opossum XT3 in the cell system 
(Ristic et al., 2005). 
 
5.3 In vitro expression models : Xenopus laevis oocytes  
 
With the identification of cDNAs encoding specific amino acid transporters, their 
expression in heterologous systems has become possible. To date, the most common in 
vitro model system being employed for the expression and investigation of amino acid 
transporters is the Xenopus laevis oocyte system.  
The oocytes of the South African clawed frog Xenopus laevis are widely used for the 
expression of heterologous proteins. Xenopus laevis is easily kept and bred in captivity 
and oocytes are easily prepared. They represent an accessible laboratory tool that 
presents different practical advantages. Since the Xenopus laevis oocytes are cells 
specialized for the production and storage of proteins for later use during 
embryogenesis, they represent a good system to translate efficiently exogenous mRNA 
into proteins. Furthermore, since mature oocytes are fully equipped with all substrates 
needed for growth, they do not need to take up nutrients from the outside and therefore 
do not express high levels of endogenous transport systems at the plasma membrane.  
In the context of mammalian amino acid transporters, oocytes could be largely used as 
expression model, despite the presence of several distinct endogenous transport 
systems. The Na+-dependent systems B0,+ for neutral and cationic amino acids (Taylor 
et al., 1989), ASC for small neutral amino acids (Campa and Kilberg, 1989) and x –ag for 
anionic amino acids (Steffgen et al., 1991) and the Na+-independent systems asc, L, y+, 
b0,+ and x-c (Ishii et al., 1991) have been detected in oocytes, but at a rather low level. 
As any heterologous expression system, the Xenopus laevis oocyte presents some 
disadvantages too. Some studies indicate that the Xenopus laevis oocytes may be 
limited in their capacity to translate selected mRNAs or to modify their protein products 
correctly (Snutch, 1988). Oocytes may also have different signaling pathways than 
32 
 genuine tissue, therefore regulation studies of the expressed proteins should be 
performed in other more appropriate expression systems. 
6. Contribution of this PhD to epithelial transport studies  
The amino acid transporters I was focusing on during my PhD work were referred as 
orphan transporters when I joined the laboratory of Prof. Verrey three years ago. The 
function of XT2, XT3, B0AT1 (at that time called simXT2) and XT3s1 was unknown. 
Many attempts to functionally characterize XT2 and XT3 had been already tried not only 
by our group but also by others (Nash et al., 1998). Initially, we tried to express them in 
heterologous systems, like Xenopus laevis oocytes, and in mammalian cell lines, such 
as MDCK and LLCPK, but the proteins could not be expressed at the cell surface, 
preventing all kind of functional studies with radiolabelled amino acids. Only a cell line 
was found to be able to express mXT2 and mXT3 at the cell surface: the OK cells. 
Focusing on XT3, all 20 amino acids and many other substances, like neurotransmitters 
and osmolytes, were offered to mXT3-expressing cells in presence and absence of Na+ 
in order to define the substrate specificity but no uptake in addition to that mediated by 
the endogenous transporters was measured for these compounds. In the mean time, 
polyclonal antibodies were raised in rabbits against all four orphan transporters and the 
first localization study was performed on mouse kidney for mXT2 and mXT3 by J. Loffing 
(formerly at the Institute of Anatomy, University of Zurich) and then also on mB0AT1 and 
mXT3s1 (Romeo et al., 2005). Our interest in XT3 led us to start a project aimed at 
producing a knockout mouse for this protein. I was working on the production of the 
targeting vector amplifing the genomic sequence from C57BL/6J ES cells but I 
encountered technical problems for the cloning of the so called long arm (see Materials 
and Methods section) and after repetitive attempts the project was discontinued. Few 
months later, Broer’s group cloned and functionally characterized the first B0-system 
transporter, mB0AT1 (Broer et al., 2004). A link between B0-system transport and 
Hartnup disorder had for long been hypothesised but the proof came from two 
independent studies, one from Broer’s group and another in which we collaborated 
(Broer et al., 2005; Kleta et al., 2004; Seow et al., 2004). Accurate genetic analysis of 
several Hartnup families revealed that many different point mutations in the gene were 
responsible for the disorder. 
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 Very recently, mXT3s1 has also been functionally characterized by two independent 
studies showing that this protein is an IMINO-transport system and renamed SIT1 
(Kowalczuk et al., 2005; Takanaga et al., 2005).  
Additional studies have been performed in our laboratories to further characterize 
mB0AT1 and mXT3s1/SIT1 using two-electrode voltage clamp techniques and 
radiolabelled amino acid uptake (Camargo SMR et al., 2005; Ristic et al., 2005). 
The physiological role of XT2 and XT3 remains unclear. The study on XT2 knockout 
mice showed a mild glycinuria with increased systolic pressure in animals lacking the 
transporter in comparison with wild type mice (Quan et al., 2004). After reading the 
publication, we found at least three points that require clarification. The first is related to 
the fact that the animals used for the analysis came from the first and second 
generation, having still a mixed genetic background 129/Sv and C57BL/6J as the mouse 
XT2 gene was isolated from a 129/Sv genomic library and the targeting vector was 
electroporated in RW4 embryonic stem cells (Quan et al., 2004). The second concerns 
the method used for the measurement of the blood pressure, namely the tail-cuff 
technique. These types of measurements require extensive handling of the animals, 
possibly leading to artefacts and gives only a punctual view of blood pressure. The third 
point is the fact that the urine amino acid measurements were not performed optimally to 
evaluate the potential decrease in amino acid reabsorption other than of glycine. For 
these reasons and in order to further characterize the phenotype of XT2-/- mice, we 
obtained from Prof. Caron few heterozygous XT2+/- males that we used for starting a 
backcross in C57BL/6J. After completing this process, the mice will be firstly screened 
for aminoaciduria and for elevated blood pressure using an implanted blood pressure 
telemeter. In addition, mice will be challenged with different protein content diets to 
assess the ability of the kidney to respond to such extreme conditions in absence of a 
potential amino acid transporter. 
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 MATERIALS AND METHODS 
 
1. Cell culture 
 
1.1 Opossum kidney cells 
 
Opossum kidney (OK) cells were cultured at 37°C and 5% CO2 in Dulbecco’s Modified 
Eagle Medium (DMEM) (Gibco, Basel, Switzerland) and Ham’s F12 Nutrition mixture 
(Gibco, Basel, Switzerland) 1:1 in presence of 5×104 units penicillin/liter (Sigma Aldrich, 
Switzerland), 50 mg streptomycin/liter (Sigma Aldrich, Switzerland), 2 mM L-glutamine 
(Sigma Aldrich, Switzerland), 40 mM HEPES (Sigma Aldrich, Switzerland) and 10% fetal 
calf serum (Sigma Aldrich, Switzerland). 
At confluency cells were subcultured with 0.25% trypsin in 0.53 mM EDTA solution, after 
removal of the culture medium and extensive washing with PBS (phosphate buffered 
saline pH 7.4).  The subcultivation ratio was 1:10 for maintenance of the cells in culture 
and plated on 100 mm plastic culture dishes (Corning, Fisher Scientific AG, Wohlen, 
Switzerland). 
 
1.2 mXT3 stably transfected OK cell line 
 
Cells for transient transfection were subcultivated 1:15 and plated on 35 mm or 60 mm 
plastic culture dishes (Corning, Fisher Scientific AG, Wohlen, Switzerland). Transfection 
was performed the day after the subcultivation using FuGene 6® transfection reagent 
(Roche Diagnostics Schweiz AG, Rotkreuz, Switzerland). 1 µg of mXT3-pIRES-CD8 
(pIRES-CD8 vector was constructed based on pIRES-neo, BD Biosciences Clonetech, 
with the addition of the sequence encoding for the CD8; kindly given by Michel Fink)  
(Fig. 1)  plasmid DNA was pre-mixed with 3 µl of FuGene 6® and incubated for 15 
minutes at room temperature before applying the mixture to the cells. Cells undergoing 
transfection received a medium change just before the application of the transfection 
mixture:  the recommended medium was as the normal culture medium but without 
antibiotics and without fetal calf serum (minimal medium). Transfected cells were kept in 
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 the minimal medium for 4 hours, then a same volume of complete culture medium was 
added. 
Cells were incubated at 37°C and 5% CO2 for 36-48 hours before selection was 
performed. 
 
Figure 1. pIRES-CD8 vector.  The vector was constructed based on pIRES-neo (BD 
Biosciences Clonetech) with the addition of the sequence coding for CD8. mXT3 was 
inserted in the multiple cloning site (MCS) using the restriction site for Eco RI. 
Amp r: ampicillin resistance gene; PCMV IE: promoter for the encephalomyocarditis 
virus; IVS: Synthetic intron; IRES: Internal ribosome entry site; CD8: sequence coding 
for the CD8 receptor; Poly A: polyadenilation site. 
 
 
Selection was performed using anti-CD8 coated metallic beads (Dynal biotech, 
Invitrogen Corporation, Oslo, Norway) which were incubated with the cells for 5 minutes 
at room temperature and rocked on a bench shaker. Cells were then trypsinized as 
described above and collected in a 15 ml Greiner tube (CellStar, E&K Scientific 
Products, California, USA). By using a 10 cm long, 3 cm wide magnet cells with beads 
interacting with the CD8 (possibly expressing also mXT3) were separated from all the 
36 
 others. Cells with beads were then plated in 35 mm dishes and kept in culture till 
confluence was reached. 
A further selection was performed after 1 week with the same procedure.  Cells still 
expressing the CD8 were collected, diluted 100 times and plated in 96-well culture plate 
in order to have ideally one cell/well. 
Cells in the 96-well plate were grown till confluence, trypsinized and plated on 35 mm 
dishes, half of them having a glass coverslip for further immunofluorescence procedure. 
Cells on glass coverslip at confluence were fixed in 4% paraformaldeyde-PBS solution 
(pH 7.4) and stained with anti-mXT3 affinity purified antibody (see below). 
 
2. Animal model: mice 
 
2.1  Housing and handling 
 
Male C57BL/6J mice were used for different experiments further described in this 
section. The approximate age of the animals ranged from 6 to 12 weeks. Mice were 
housed in the Animal facility of the Institute of Physiology, University of Zurich, under the 
supervision of qualified personnel from the Institut für Labortierkunde (LTK) of the 
University of Zurich. 
Mice were housed in groups of 3 to 5 in the Tecniplast Sealsafe™ Individually Ventilated 
Cages (IVC) (dimensions 365 x 207 x 140 mm 1284L Eurostandard Type II L, 
Techniplast) or in groups of maximum 3 animals in smaller filter top cages (dimensions 
267 x 207 x 140 mm; 1264C Eurostandard Type II, Techniplast). 
In IVCs filtered air is delivered to the cage top level through a self-closing valve when 
docked in position on a Sealsafe rack. Exhaust air exits the cage through an 
independent  self-closing valve, to avoid commixture of air.  
Animal handling was according to the Swiss Animal Welfare laws and approved by the 
Kantonales Veterinäramt Zürich. All the people involved in the animal handling received 
at least the basic one-week animal handling course (Module 1 LTK) from the Institut für 
Labortierkunde (LTK) of the University of Zurich (see certificate of attendance in the CV 
section). 
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 Specific procedures used for the below mentioned experiments are explained in detail in 
the next sections. 
 
2.2  Tissue preparation for immunohistochemistry, protein extraction and total RNA 
extraction 
 
2.2.1 For immunohistochemistry 
 
Male C57BL/6J mice (10-12 weeks old) were anesthetized with ketamine and 
xylazine i.p. and perfused through the left ventricle with PBS followed by a buffered 
paraformaldehyde solution (4%, pH 7). Kidneys and small intestine were removed, 
flushed with fixative solution, cut and embedded in Tissue-Tek® O.C.T™ Compound 
(Sakura Finetek Europe B.V., The Netherlands) just before freezing in liquid nitrogen. 
 
2.2.2 For protein extraction 
 
Male C57BL/6J mice (10-12 weeks old) were anesthetized with ketamine and 
xylazine i.p. followed by cervical dislocation and organs were rapidly harvested. The 
segment from duodenum to ileum was harvested, rinsed several times with ice-cold 
PBS (phosphate buffered saline pH 7.4) and the mucosa cell layers were scraped off 
on ice and transferred into ice-cold  homogenization buffer (300 mM mannitol, 5 mM 
EGTA, 12 mM Tris HCl, pH 7.1) with protease inhibitor cocktail (Sigma-Aldrich, 
Switzerland), containing 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF), 
pepstatinA, E-64, bestatin, leupeptin, and aprotinin. Kidneys were harvested too. The 
samples were homogenized with a tip sonicator, 10 mM MgCl2 was added and 
samples kept on ice for 30 min. Samples were then centrifuged 15 min at 900 g. The 
supernatant was then centrifuged at 12000 g for 30 min at 4 °C and the pellet 
resuspended in membrane buffer (300 mM mannitol, 20 mM Hepes Tris pH 7.4) 
containing protease inhibitor cocktail. 
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 2.2.3 For total RNA extraction 
 
Male C57BL/6J mice approximately 12 weeks old were sacrificed by i.p. injection of 
ketamine/xylazine and subsequent cervical dislocation; tissues were collected and 
rapidly frozen until further use. Stomach, duodenum, jejunum, ileum and colon were 
harvested, rinsed several times with ice-cold PBS (phosphate buffered saline pH 7.4) 
and the mucosa cell layers were scraped off on ice and rapidly frozen. The 
duodenum was identified as proximal of the ligament of Treitz (first 2 cm), the 
jejunum as the upper part (upper 2/5) of the small intestine distal of the ligament of 
Treitz and the ileum as the lower part (lower 2/5) of the small intestine ending before 
the caecum. Between duodenum and jejunum, 5 cm of tissue were removed as a 
safety margin as well as 10 cm between jejunum and ileum. Total colon was used for 
mucosa isolation. 
 
2.3 Treatments of WT C57BL/6J mice with modified food/water   
 
2.3.1 High and low sodium diets 
 
Three groups of six male C57BL/6J mice each, approximately 10 weeks old, were 
housed in three independent IVCs and received for 48 hours one of the following diet 
regimes: 
- control animal group: 0.3% NaCl pellet food and tap water ad libidum; 
- low sodium animal group: sodium free pellet food and tap water ad libidum; 
- high sodium animal group: 0.3% NaCl pellet food and 2% sucrose /3% NaCl in 
the drinking water ad libidum. 
 
2.3.2 Induction of metabolic acidosis/alkalosis 
 
Three groups of five male C57BL/6J mice each, approximately 8-10 weeks old, were 
housed in three independent IVCs and received for 7 days one of the following diet 
regimes: 
- Control animal group: regular pellet food and tap water ad libidum; 
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 - Acidosis animal group: regular pellet food and 2% sucrose/0.28 M NH4Cl in the 
drinking water ad libidum;  
- Alkalosis animal group: regular pellet food and 2% sucrose/0.28 M NaHCO3 in the 
drinking water ad libidum. 
 
2.4  XT2 heterozygous mice  
 
2.4.1 Generation of XT2 KO mice (by Dr. Hui Quan, Prof. Marc Caron’s group, Duke 
University Medical Center, Durham, NC, USA) 
 
The mouse XT2 gene was isolated from a 129/Sv genomic library. A targeting vector 
was constructed by using an 8-kb genomic DNA fragment containing exon 1 and intron 
1. A DNA fragment containing the whole exon 1 and part of intron 1 was replaced by a 
3.5-kb loxP-flanked Neo-TK selection cassette (Fig. 2), and a PGK-DT cassette was 
inserted upstream for negative selection. The vector was linearized at a unique NotI site 
and electroporated into RW4 embryonic stem (ES) cells. Homologous recombinants 
were screened from the G418-resistant colonies by PCR and confirmed by Southern blot 
analysis. Male chimeras produced by injection of targeted ES cells into C57BL/6J 
blastocysts were bred with C57BL/6J females. Germ line transmission of the targeted 
mutation was screened by PCR and verified by Southern blot analysis of tail DNA. 
Heterozygotes were then mated with transgenic C57BL/6J mice carrying a CMV-Cre 
transgene (a gift from Yuan Zhuang at Duke University). Constitutively expressed Cre 
recombinase excises the loxP-flanked Neo-TK cassette, which renders heterozygous 
animals without the Neo-TK selection cassette (XT2+/–) (Quan et al., 2004). 
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Figure 2. Generation of XT2-null mutant mice. Targeting strategy for disruption of the 
XT2 gene. 
 
2.4.2 Backcrossing of XT2 heterozygous mice with C57BL/6J mice and genotyping 
 
Heterozygous male mice, approximately 8 weeks old, were kindly given to us by Prof. 
Marc Caron (Duke University Medical Center, Durham, NC, USA). After one week 
recovery in the Animal Facility of the Institute of Physiology (University of Zurich) mice 
were paired 1:1 with C57BL/6J wild type female mice, approximately 8 weeks old.  At 
each generation tail biopsies were collected from 4 weeks old pups, digested overnight 
at 55 °C in 400 µl of lysis buffer containing 100 mM Tris HCl pH 8.5, 5 mM EDTA, 0.2% 
SDS, 200 mM NaCl and 200 µg/ml Proteinase K (Sigma-Aldrich, Buchs, Switzerland). 
After heat inactivation of the enzyme for 10 minutes at 95 °C, 100 µl of 5 M NaCl and 
DNA was extracted by adding 500 µl of Chloroform-Isoamylalcool (49:1) (Sigma-Aldrich, 
Buchs, Switzerland). Samples were vortexed and centrifuged 5 minutes at 14000 rpm in 
a bench-top centrifuge (Vaudaux-Eppendorf AG, Basel, Switzerland). The aqueous 
supernatant phase  was transferred to a fresh tube and DNA was precipitated by adding 
1 volume of 2-Propanol (Sigma-Aldrich, Buchs, Switzerland). To allow the DNA 
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 precipitation the samples were kept a -20 °C for at least 30 minutes before centrifuging 
them for 5 minutes at 14000 rpm in a bench-top centrifuge. The pellet was then washed 
with 70% Ethanol solution and centrifuged again. Pellet was dried at least 30 minutes at 
room temperature and then resuspended in DNase-free water. Concentration of the 
samples was measured with UV/VIS spectrophotometer (Biorad, Hercules CA, USA). 
100 µg of DNA was further used for PCR.  PCR reaction was performed in presence of 
16.6 mM ammonium sulfate, 6.7 mM MgCl2, 67 mM Tris HCl pH 8.8, 5 mM β-
mercaptoethanol, 6.7 µM EDTA, 1 mM each dNTPs, 10% DMSO, 0.32 mM sense 
primer, 0.5 mM antisense primer and 1.25 unit of EurobioTaq® DNA polymerase 
(Eurobio Laboratories, France).  The reaction were run in a bench-top PCR cycler: initial 
denaturation 1 minute and 30 seconds at 93 °C, 40 cycles 93 °C 30 seconds, 57 °C 30 
seconds, 72 °C 3 minutes, final elongation 72 °C for 5 minutes. Half of the reaction was 
loaded on a 1% agarose gel containing 0.5 µg/ml ethidium bromide. In Figure 3 a 
representative gel showing the genotype of several screened mice.  
Two to three heterozygous males were chosen for further backcrossing with WT 
C57BL/6J females. At the forth generation genomic DNA from six heterozygous males 
was further analysed for 96 C57BL/J6 markers using GenoMouse Kit (Elchrom 
Scientific, Cham, Switzerland). Every DNA is tested for 96 specific C57BL/J6 genetic 
markers spread on all the 19 autosomes by PCR. The reaction is also performed on a 
C57BL/6J WT mouse as reference. Results are then compared and heterozygous mice 
carrying the highest number of C57BL/6J markers are selected for furher backcrossing. 
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Figure 3. Genotyping results. Analysis of mouse XT2 genomic PCR product in a 1.0% 
agarose gel stained with ethidium bromide. A PCR product of 526 bp is seen in wild-type 
(+/+) and heterozygous mutants (+/-) together with a 421-bp fragment which would be 
the only fragment present in homozygous mice (not shown). Con: control PCR with WT 
genomic DNA; wat: reaction with no template present; mA: mβ-actin internal PCR 
control (size of the fragment 756 bp); M: molecular weight marker. The two arrows 
indicate the sizes of the specific bands. 
 
2.4.3 Telemetry Probe Implantation Procedure 
 
A system for telemetric measurements using the DSI radiotelemetry system (Data 
Sciences International, St. Paul, MN) with the TA11PA-C10 pressure and activity implant 
(Data Sciences International, St. Paul, MN) was set up at the Institute of Physiology. 
For data collection and analysis a Dataquest ART Data Exchange Matrix and a 
Dataquest Acquisition and Analysis System ART (Data Sciences International, St. Paul, 
MN) were purchased. 
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 2.4.3.1 Pressure-sensing catheter implantation 
 
Male and female C57BL6/J XT2 wild type (XT2+/+), heterozygous (XT2+/-) and 
homozygous (XT2-/-)  mice were anesthetized with ketamine (65 mg/kg ip), xylazine (13 
mg/kg ip) and ace promazine (2 mg/kg ip), and the neck was shaved and disinfected. 
Animals were placed on their backs on a heated surgical surface with forelimbs secured 
using tape and the head held parallel to the body by a small piece of tubing looped 
around the upper incisors and anchored to the surface. This allows easier access to the 
region to be dissected. A ventral midline skin incision was made from the lower mandible 
posteriorly to the sternum ( 3 cm), and the submaxillary glands were gently separated 
using sterile cotton swabs. The left common carotid artery was isolated using fine 
forceps, with care being taken to avoid disturbing nerve fibers running parallel to the 
artery. The left carotid is preferable, since the right brachiocephalic artery branches off 
from the right carotid artery, potentially compromising blood flow to this region. Two silk 
ligatures (7–0, Braintree) were passed under the vessel and used for both ligation and 
retraction. The anterior silk suture, placed just caudal to the bifurcation of the interior and 
exterior carotid arteries, was used to ligate the artery. The posterior suture, placed 
loosely about 0.5 cm from the anterior tie, was used for temporary occlusion of the artery 
during catheter insertion. Gentle tension was applied to both ligatures to slightly retract 
and lift the vessel before making a tiny incision in the carotid artery just posterior to 
suture a using Vannas spring micro-scissors (Fine Science Tools, catalog no. 15610-
08). After carefully removing the protective cover from the tip of the catheter, the 
catheter was gently grasped using vessel cannulation forceps (Fine Science Tools, 
catalog no. 00608-11) and inserted into the carotid artery with the aid of fine forceps 
used to hold the vessel incision open. The occlusive posterior ligature was released, and 
the catheter was advanced to the point where the small notch on the tubing (the 
transition between the thin-walled tubing and remaining outer tubing, 10 mm from the tip) 
resided at the vessel opening. Inserting the catheter up to this landmark notch assures 
the critical placement of the pressure-sensing tip just inside of the thoracic aorta. The 
notch also serves as a useful tool for anchoring the catheter into the vessel; the loose 
ends of anterior ligature were tied securely around the catheter at the notch. The loose 
ends of the occlusive posterior ligature were also brought up and tied securely around 
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 the vessel/catheter. A single microdrop of Nexaband veterinary adhesive was applied to 
the site of catheter insertion into the vessel. It should be emphasized that that only a 
very small amount of adhesive is required, and that care should be taken to avoid undue 
application of adhesive to surrounding tissues and nerve fibers. 
 
2.4.3.2 Implantation of transmitter subcutaneously along the right flank 
 
Through the same ventral neck incision, a subcutaneous pouch was formed for 
placement of the transmitter body along the animal’s right flank. Using a pair of blunt 
dissecting scissors (Fine Science Tools, catalogue no. 14018-14), the skin was gently 
dissected free from underlying tissue starting at the right neck region and proceeding 
posteriorly to form a "pocket" along the right flank. It is important that the pocket be made 
sufficiently large to house the transmitter without unduly stretching the skin, because 
pressure necrosis could result. The transmitter was slipped under the skin and down into 
the pocket along the flank as close to the right hindlimb as possible. A small drop of 
Nexaband was placed on the catheter in the right neck region to further secure the 
device. The neck incision was closed using 6–0 silk and further sealed with tissue 
adhesive. Mice were kept warm on a heating pad and monitored closely until fully 
recovered from anaesthesia. 
 
3. Immunohistochemistry 
 
3.1  Immunolabelling procedure 
 
Frozen tissues were stored at –80°C. Serial sections of 5 µm were cut on a cryostat and 
collected on polylysine-coated slides (Kindler, Freiburg, Germany). Sections were 
incubated 5 min in SDS 0.1%, washed 3 times with PBS and then incubated with the 
primary antibodies (diluted in PBS, TritonX-100 0.04%) 1 hour at room temperature. 
Sections were then washed 3 times and incubated with the secondary antibody (diluted 
in PBS, TritonX-100 0.04%) for 1 hour at room temperature. After washing 5 times the 
sections were mounted using DAKO Mounting medium (DakoCytomation Denmark A/S, 
Denmark). Sections were viewed on  Leica SP1 UV CLSM confocal microscope (Leica 
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 Microsystems Inc., Buffalo New York, USA). Images were further processed (merged) 
using Photoshop 7. 
 
3.2  Antibodies 
 
Rabbit-anti-mB0AT1 antibody (NH2-terminal; antigen peptide NH2-MVR LVL PNP GLE 
ERIC- CONH2 (16aa); affinity purified antibody, dilution 1:200), rabbit-anti-mXT2 (NH2-
terminal; antigen peptide NH2- MAQ ASG MDP LVD IED ERC -CONH2 (18 AA); affinity 
purified, dilution 1:200), rabbit-anti-mXT3 (NH2-terminal; antigen peptide NH2- MES PSA 
HAV SLP EDE ELC -CONH2 (18 AA); affinity purified, dilution 1:200), rabbit-anti-
mXT3s1 (COOH-terminal; antigen peptide NH2-CIRN RLK RGG SAP VA -COOH (15 
AA); affinity purified antibody, dilution 1:200) and goat-anti-m4F2hc (Santa Cruz Biotech, 
Santa Cruz CA,USA, 1:400). Secondary antibodies were Alexa Fluor® 594 donkey anti-
rabbit IgG (1:1000; Molecular Probes, Portland, Oregon, USA) and Alexa Fluor® 488 
donkey-anti-goat IgG (1:500; Molecular Probes, Portland, Oregon, USA). The secondary 
antibodies alone as well as antibodies pre-incubated with the specific peptides (1 hour at 
room temperature) did not produce any significant staining in all tissues tested. 
 
4. Western blotting 
 
4.1  General procedure 
 
After measurement of the total protein concentration (BioRad protein kit, Biorad, 
Hercules CA, USA), 20 µg of BBMVs (brush-border membrane vesicles) were used for 
the deglycosylation reaction as described below. Samples were solubilized in Laemmli 
sample buffer, and separated on a 10% polyacrylamide gel. For immunoblotting, 
proteins were transferred electrophoretically from unstained gels to PVDF-membranes 
(Immobilon-P, Millipore, Bedford, MA, USA). After blocking with 2% Top BLOCK™ 
powder (Juro, Lucerne, Switzerland) in Tris-buffered saline/0.1% Triton X-100 for 60 min 
at room temperature or overnight at 4° C, the blots were incubated with the primary 
antibodies for 3 hours at room temperature or overnight at 4 °C. The primary antibodies 
were the same affinity purified rabbit antibodies as described in the previous paragraph 
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 and all were used at a 1:1000 dilution. After washing and subsequent blocking for 1 hour 
at room temperature, blots were incubated with secondary antibody goat anti-rabbit 
conjugated with Horseradish Peroxidase (1:10,000; BD Transduction Laboratories, 
Lexington, KY, USA) for 1 h at room temperature. Antibody binding was detected with 
the SuperSignal® West Pico Substrate (Pierce Socochim, Lausanne, Switzerland). 
Chemiluminescence was detected with a DIANA III camera (Raytest Schweiz, Dietikon, 
Switzerland). The specificity of the antibodies used was tested using preincubation (1 h 
at room temperature) with the immunizing peptides (final concentration peptide: 200 
µg/ml XT2 and 400 µg/ml B0AT1, XT3 and XT3s1). 
 
4.2  Endo-beta-N-acetylglucosaminidase F (PNGase F) assay 
 
Hydrolysis of Asn-oligosaccharides was carried out using endo-beta-N-
acetylglucosaminidase F enzyme (New England Biolabs, USA). 20 µg of kidney or small 
intestine brush-border membrane vesicles (BBMVs) from adult (10-14 weeks old) 
C57BL/6J and NRMI mice were the substrate for the enzyme. The samples were first 
heated at 65 °C for 15 minutes in the provided buffer containing β-mercaptoethanol and 
SDS. The reaction mix was then incubated 1 hour at 37 °C in the reaction buffer and 1% 
NP-40 in the presence or absence of the enzyme. The reaction mixture was run on a 
10% SDS-polyacrylamide gel and the Western blotting performed as described 
previously. 
 
5. RT-real time PCR 
 
5.1  RNA extraction and reverse transcription (RT) reaction 
 
Total RNA was extracted from the different tissues using the RNeasy Mini Kit (Qiagen 
AG, Basel, Switzerland). For RNA extraction, tissues were thawed in RLT buffer 
(Qiagen) containing 10 µl/ml of β-Mercaptoethanol (Sigma-Aldrich, Buchs, Switzerland) 
and homogenized on ice. RNA was bound to columns and treated with DNase for 15 
minutes at 25°C to reduce genomic DNA contamination. Quantity and quality of total 
eluted RNA were assessed by spectrometry and agarose gel electrophoresis. Each RNA 
47 
 was diluted to 100 ng/µl and 1 µl was used as template for reverse transcription with 
TaqMan® Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA) in 
presence of 2.5 µM of Random Hexamers primers (Applied Biosystems). 
 
5.2  Real time PCR 
 
Real-time PCR was performed using as template 1 µl of cDNA synthetized by reverse 
transcription. The reaction was set up following the Applied Biosystems 
recommendations in the TaqMan® Universal PCR master mix (Applied Biosystems). 
Primers and probes were designed using Primer Express software from Applied 
Biosystems. Primers were chosen to result in amplicons of 70-100 bp that span the 
intron-exon boundaries, to avoid the effects of potentially contaminating genomic DNA. 
The specificity of the primers was first tested on cDNA derived from several tissues and 
resulted in a single product of the expected size (data not shown). Probes were labelled 
with reporter dye FAM at the 5’ end and the quencher dye TAMRA at the 3’ end 
(Microsynth, Balgach, Switzerland). Reactions were run in 96-well optical reaction plates 
using a Prism 7700 cycler (Applied Biosystems). Thermal cycles were set at 95°C (10 
minutes) and the 40 cycles at 95°C (15 seconds) and 60°C (1 minute) with auto ramp 
time. To analyze the data, the threshold was set to 0.06 (value in the linear range of 
amplification curves). All the reactions were run in duplicates. The abundance of the 
target mRNAs was calculated relative to a reference mRNA (mGAPDH). Assuming an 
efficiency value of 2 (fold-increase in input mRNA required to decrease the cycle number 
by 1), relative expression ratios were calculated as R = 2(Ct(GAPDH) – Ct(test)), where Ct is the 
cycle number at the threshold and test stands for the tested mRNAs (Dave et al., 2004). 
 
6. Targeting vector preparation for knocking out XT3 gene in mouse 
 
XT3 gene is located on chromosome 9. The whole gene of about 40 kb is constituted by 
11 exons and 10 introns. In the intronic sequence between the first and the second exon 
there are three gaps of unknown sequence. Therefore, this region has not been 
considered for the design of the knockout vector. (Figure 5A) 
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 The targeting vector (kindly provided by Rainer Waldmann, Sophia Antipolis, France, to 
Prof. Warth, formerly at our Institute) contains two negative selection markers, thymidine 
kinase (TK) and diphtheria toxin (DT) together with a positive selection marker, neo 
(neomycin resistance gene). Three loxP sites flank the neomycin resistance gene and 
can be used for the generation of conditional knockout constructs. (Figure 4)  
The final vector configuration is shown in Figure 5B. 
 
... neo TKT3 T7DT
FseIHindIIISwaI
loxP siteloxP site loxP site
NotI SfiIAscI
...
 
Figure 4. Targeting vector. The unique restriction sites are indicated with arrows. DT: 
diphtheria toxin; TK: thymidine kinase; neo: neomycin resistance gene; T3 and T7: 
bacterial RNA polymerase promoters. 
 
 
Oligonucleotides have been designed on exon 3 (sense primer 5’- 
GGCCTCTGTGTACTTCAATG-3’) and on exon 5 (antisense primer 5’- 
TGTGAACATGTATGCCAGG-3’) for the PCR amplification of a 2.8 kb fragment, so 
called short arm of the targeting vector. Another couple of oligonucleotides were placed 
on exon 6 (sense primer 5’-TGGGCTTAGGGTGTGGTG-3’) and exon 8 (antisense 
primer 5’-GGATGGCCGTTCCTGTC-3’) to produce a fragment 6.4 kb long, so called 
long arm.  
The template used in the PCR reaction is the genomic DNA extracted from C57BL6 ES 
cells (kindly provided by Prof. B. Ledermann, Institute für Labortierkunde, University of 
Zürich).  All PCR reaction were performed using  Pfu Turbo DNA Polymerase 
(Stratagene, La Jolla, CA) using the buffer supplied by the company and following the 
protocol optimized by the company, in presence of 0.5 µM each primers 
(oligonucleotides) and 0.2 mM each dNTPs. 
Oligonucleotides (Microsynth, Balgach, Switzerland) for the amplification of the short 
arm produced a 2.8 kb-fragment that was purified over a 0.7% agarose gel using 
QIAquick Gel Extraction Kit (Qiagen AG, Basel, Switzerland). At the same time, the 
targeting vector was digested with 10 units/µg of DNA with SwaI restriction enzyme 
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 (New England Biolabs, USA) in order to obtain blunt ended extremities, which would be 
compatible for ligation with the blunt ended fragment generated by Pfu Turbo DNA 
polymerase. The digested vector was then dephosphorylated with Calf Intestinal Alkaline 
Phosphatase (CIAP) (Promega, Catalys AG, Wallisellen, Switzerland). Ligation followed 
the dephosphorylation reaction: the PCR fragment and the dephosphorylated vector 
were mixed in presence of T4 DNA ligase (Promega, Catalys AG, Wallisellen, 
Switzerland) and incubated overnight at 16 °C.  XL-1 Blue Supercompetent cells 
(Stratagene, La Jolla, CA) were chemically transformed using 10% of the ligation 
reaction. Clones were screened by gel electrophoresis after specific endonuclease 
digestion to confirm the presence of the insert in the vector and to check its correct 
orientation. 
As it was not possible to obtain the long fragment from a single PCR reaction, a unique 
restriction site (AflII) in the intronic sequence between exon 7 and 8 was selected to be 
further used to join two halves of the long arm. PCR was performed with two new sets of 
oligonucleotides designed one on exon 6 just before the FseI restriction site (sense 5’-
ATAACTGGCCGGCCTCATTGTGTCTGTCATC-3’) and intron between exons 7 and 8 
after AflII restriction site (antisense primer 5’-GAAAAGGTGGGTCAAAATAATG-3’) and 
the other set on the intron spanning exons 7 and 8  before the AflII restriction site (sense 
primer 5’-GGCCTGTGATTCTGGTTGC-3’) and the intron between exons 8 and 9 soon 
after the AscI restriction site (antisense primer 5’-
GTAGATGGCGCGCCGTTCCTGTCCCC-3’). PCR fragment were separated on 0.7% 
agarose gel and purified as described above. The two fragments were then ligated in 
pBluescript II SK(-) (Stratagene, La Jolla, CA) previously digested with EcoRV 
endonuclease (Promega, Catalys AG, Wallisellen, Switzerland) to allow blunt end 
ligation as described previously. After bacterial transformation, clones were screened. 
Correct clones were further digested with FseI-AflII endonucleases (New England 
Biolabs, USA) for the fragment obtained with the first set of primers and with AflII-AscI 
(New England Biolabs, USA) for the fragment obtained with the second set of primers. 
Excised fragments were gel purified and ligation was performed by mixing the two 
halves of the long fragment with the targeting vector previously digested with FseI and 
AscI (New England Biolabs, USA).  The junction of the two parts was not successful.  
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 Therefore, other trials to obtain the full length long arm were made, using the original  
oligonucleotide pair placed on exon 6 (sense primer 5’-TGGGCTTAGGGTGTGGTG-3’) 
and exon 8 (antisense primer 5’-GGATGGCCGTTCCTGTC-3’). Finally, the expected 
size band was obtained, purified using QIAquick Gel Extraction Kit (Qiagen AG, Basel, 
Switzerland), digested with FseI and AscI endonucleases and ligated in the vector 
previously digested with the same pair of restriction enzymes.  Also in this case the 
reaction was not successful and the project was temporarily discontinued.  
 
5 6 7 8
SwaI SwaI FseI AscI
DT TKT3 T7
3 4
Targeting vector
Homologous recombination
......
ATG TGA
1 2 3 4 5 6 7 8 9 10 11
mXT3 gene (chomosome 9)
~ 2.8 Kb ~ 6.4 Kb
Not I Sfi I
(with short and long arms)
pBluescript
exons
A
B
......
ATG TGA
1 2 3 4 5 6 7 8 9 10 11
mXT3 gene (chromosome 9)
exons
C
neo
neo
 
Figure 5. Models of the XT3 gene on mouse chromosome 9 (A), of the targeting vector 
containing the short (inserted in the SwaI restriction site) and the long (inserted between 
FseI and AscI restriction sites) arms (B) and of the modified XT3 gene after homologous 
recombination in transfected ES cells (C). 
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 RESULTS 
 
1. mXT3 stably transfected OK cells 
 
The expression of B0-cluster transporters in epithelial cell lines has been initiated in the 
laboratory of Prof. Verrey first with XT2 and XT3 several years ago. Several attempts by 
a former PhD student using the kidney epithelial cell lines mpkCCD, MDCK and HEK-
293 did not elicit any amino acid transport and using polyclonal antibodies raised in 
rabbits in was shown in all these cell lines that the transporters remained intracellular 
(Ristic, unpublished results).   
Encouraging results were obtained when I expressed mXT2 and mXT3 cDNAs in the 
Opossum Kidney (OK) cell line. These cells were chosen for two main reasons: first OK 
cells express many proximal tubule cell-like properties in vitro and second, they are easy 
to transfect.  
Particular emphasis was given to the expression and subcellular localization of mXT3. 
The first results of immunolocalization of transiently transfected OK cells with cDNA 
coding for XT3 showed mostly an apical “patchy” pattern of fluorescence which 
represents the OK cells microvilli with XT3 transporter. A similar pattern had been shown 
before for sodium-phosphate (Na-Pi) type IIa cotransporters in OK cells (Hernando et 
al., 2000). We need to mention that the efficiency of transient transfection of OK cells 24 
h after addition of XT3 cDNA was ~ 10-20%. The immunohistochemistry was performed 
when the culture reached confluence (after 72 h) and at this stage the number of 
transfected cells was low.  
For this reason, we produced a stably transfected OK cells using cDNA coding for 
mouse orphan transporter XT3 and CD8. Cells were selected using anti-CD8 metallic 
beads as described in details in the “Materials and Methods” section. Expression of XT3 
transporter was analyzed by immunofluorescence, showing that stably expressed XT3 is 
localized at the apical membrane of OK cells (Figure 1). The observed different sorting 
behaviour of the same transporter in different cell lines confirmed the hypothesis that not 
only molecular determinants on the transporter are decisive for an apical sorting, but that 
also the cellular context is of importance. 
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 Several attempts were made to differentiate the transport due to exogenous XT3 from 
the endogenous one and from the other transport systems in the OK cells but without 
success. One reason for this failure might be that the activity of the exogenous 
transporter was masked by the one of the endogenous XT3 and probably by other 
amino acid transporter systems of these cells. 
We therefore decided to take another approach focusing on the characterization of OK 
cell endogenous transporters (Ristic et al., 2005). 
 
antibody:                                            anti-XT3 
cell line:                  XT3                                                 wt 
 
 
 
 
 
 
 
 
 
Figure 1. Immunofluorescence of OK cells. The stable XT3-transfected protein is 
expressed at the apical membrane of OK cells within microvilli. XT3-transfected and 
untransfected OK cells were grown to confluence on glass coverslips and further 
processed for immunofluorescence. Double staining of nuclei in blue and XT3 protein in 
red. 
 
2. Localization of SLC6 transporters of B0AT-cluster 
 
2.1 Tissue mRNA distribution of B0AT-cluster transporters 
 
The results presented in the next 6 pages have been published on The American 
Journal of Physiology (Romeo et al., 2005).  
The relative abundance of mRNAs encoding the four related transporters B0AT1, XT2, 
XT3 and XT3s1/SIT1 was measured in several organs/tissues by Taq Man® real-time 
RT PCR using GAPDH as internal standard.  Figure 2 shows the relative abundances of 
these transcripts. A high expression level of all four mRNAs was found in kidney, relative 
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 to GAPDH approximately 10% for B0AT1, XT2 and XT3 and 1% for XT3s1. In small 
intestine mucosa, the level of B0AT1 mRNA was similar to that found in kidney and 
XT3s1/SIT1 mRNA was abundant as well. In contrast, XT2 and XT3 mRNAs were 100- 
to 1000-fold less abundant and displayed an axial gradient towards the ileum. In all 
tested tissues but muscle (and very low in heart) the transcript of at least one of these 
transporters was detected. Interestingly, the spleen that is not considered as an 
epithelial organ does express all four mRNAs to some extent. In the brain, XT3s1/SIT1 
showed the strongest expression while no XT2 mRNA was detected. In contrast to some 
of our negative data obtained by TaqMan® real time RT-PCR on tissues of two 
C57BL/6J mice, a recent publication showed qualitatively the expression of XT3 mRNA 
in mouse lung and of XT3s1/SIT1 mRNA in mouse muscle and hearth (Kowalczuk et al., 
2005). We have no explanation for this difference that could be of technical nature or 
due to the use of another mouse strain. 
 
Figure 2. Relative mRNA abundance of mB0AT1, mXT2, mXT3 and mXT3s1/SIT1. 
The abundance of mRNAs was measured by real time RT-PCR (see Material and 
Methods) and the level of the tested transporter mRNAs relative to that of GAPDH is 
indicated for each tissue. A relative abundance of 1 corresponds to the copy number of 
GAPDH mRNA the expression of which was relatively homogenous within RNA of 
epithelial tissues (cycle number to reach threshold (Ct): from 23.23 for kidney to 26.59 
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 for colon) and other tissues (Ct 22.74 for heart to 28.81 for spleen). Significant 
expression of all four B0AT-cluster mRNAs was found in kidney and small intestine 
where B0AT1 and XT3s1/SIT1 mRNAs were the highest. XT3s1/SIT1 mRNA is also 
abundant in brain, testis, spleen, stomach and lung. The mean relative mRNA 
abundance tested independently in two mice is shown. Values are expressed as mean ± 
S.E.M.  
 
 
2.2 Glycosylation of B0AT1 and related transporters 
 
B0AT1 displays five or six N-glycosylation consensus sites within its putative 
extracellular loops that are distant enough from the closest transmembrane segment to 
be potentially glycosylated (http://www.cbs.dtu.dk/services/NetOGlyc/). In contrast, the 
three transporters XT2, XT3 and XT3s1/SIT1 display only two to three such potentially 
glycosylated consensus sites (Bennett and Kanner, 1997; Chen et al., 1998; Mingarro et 
al., 2000). Figure 3 shows the effect of the treatment of small intestine and kidney brush 
border vesicle proteins with endo-beta-N-acetylglucosaminidase F (PNGase F), an 
enzyme that cleaves off high-mannose and terminally glycosylated N-glycans (Elder and 
Alexander, 1982). 
 
Figure 3. Endoglycosidase assay on kidney and small intestine BBMVs. 20 µg of 
kidney and total intestine BBMVs were separated on a 10% polyacrylamide gel after 
treatment with (+) or without (-) PNGase F enzyme and submitted to Western blotting. 
XT2 and XT3 were not detected in intestine whereas the anti-XT3s1/SIT1 antibody does 
not function in Western blotting. As expected from N-glycosylation site predictions, a 
shift of the specific band towards lower molecular weights was observed for B0AT1, XT2 
and XT3.  
The particular migration of deglycosylated XT3 in comparison with deglycosylated 
B0AT1 and XT2 could be due to differential post-translational modifications not 
investigated in this study. 
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 The unique strong band corresponding to B0AT1 migrates at the level of approximately 
70 kD and deglycosylation shifts this band to approximately 48 kD. This fast migration 
for a protein with a calculated molecular weight of 71 kD could be due to its very 
hydrophobic nature. The shift in the relative migration induced by deglycosylation is 
compatible with the cleavage of four to six complex N-glycans. In the case of XT2, the 
fully glycosylated form migrates around 57 kD and the deglycosylated one around 48 kD 
(calculated MW 69 kD) as that of B0AT1. Again, the apparent MW of the deglycosylated 
form is compatible with the highly hydrophobic nature of the polypeptide and that of the 
glycosylated form suggests, as expected, the presence of two or three complex N-
glycans. The migration pattern of XT3 is more complex. There are two major bands, one 
migrating at approximately 62 kD and another, of variable intensity between 
experiments, around 120 kD. We do not know why deglycosylated XT3 migrates slower 
than B0AT1 and XT3s1/SIT1 (apparent MW of 62 versus 48 kD) and forms apparently 
also a dimer. A potential explanation for the slightly slower migration of XT3 could be a 
differential post-translational modification other than N-type glycosylation. Concerning 
the higher MW band, the most likely hypothesis is that it corresponds to a homodimer 
that resists denaturation and reduction. Endo F treatment produced a shift of both bands 
indicating the presence of N-glycans. In the case of XT3s1/SIT1 no such information 
could be obtained since the antibody failed to recognize any specific band in Western 
blot (data not shown). 
 
2.3 Axial and subcellular localization of B0AT-cluster transporters in kidney 
 
Immunohistochemistry showed that B0AT1, XT2, XT3 and XT3s1/SIT1 localize to the 
apical brush border membrane of proximal tubule cells. No specific staining was 
observed in other nephron segments or structures. The axial distribution of the four 
proteins along the proximal tubule differs, as shown in Fig. 4. The heavy chain of the 
heterodimeric amino acid transporters 4F2hc (CD98) is shown in green as basolateral 
marker (Dave et al., 2004; Rossier et al., 1999). B0AT1 is expressed mainly in the early 
proximal tubules (S1 segment) starting at the glomerulus. The distribution of XT2 along 
the proximal tubule is essentially restricted to the later segments S2 and S3 and thus 
quite complementary to that of B0AT1. XT3 and XT3s1/SIT1 were detected in the brush 
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 border membrane all along the proximal tubule, their levels decreasing slightly towards 
the end (Fig. 4g). The axial distribution of the transporters (red) is clearly visible in the 
low magnification pictures of consecutive mouse kidney sections (Fig. 4a-d) while the 
characteristic brush-border membrane staining is appreciable in the high magnification 
pictures (Fig. 4e-h).  
 
Figure 4. Localization of B0AT1, XT2, XT3 and XT3s1/SIT1 in kidney. 
Immunohistochemistry localized each of the four proteins to the brush-border membrane 
of kidney proximal tubules (red) while 4F2hc (CD98) was used as basolateral marker 
(green). The upper row shows consecutive overview sections of kidney cortex while the 
lower row shows higher magnifications. a and e, B0AT1; b and f, XT2; c and g, 
XT3s1/SIT1; d and h, XT3. The bars are in the upper row 100 µm and 50 µm in the 
lower row. Gl, glomerulus. 
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 2.4 Segmental and subcellular localization of B0AT-cluster transporters in small 
intestine 
 
All along the mouse small intestine (duodenum, jejunum and ileum), the affinity purified 
anti-B0AT1, anti-XT2 and anti-XT3s1/SIT1 antibodies showed a strong apical staining of 
the enterocytes lining the intestinal villi whereas no signal was detected with the anti-
XT3 antibody. The staining is shown in Fig. 5 for jejunum with the four B0-cluster 
transporter antibodies (red channel) and anti-4F2hc (green channel) as basolateral 
marker (Dave et al., 2004; Rossier et al., 1999). Mucus-secreting goblet cells did not 
show any basolateral or apical staining, indicating that these transporters are expressed 
only by the transporting enterocytes.  
The fact that staining was observed for XT2 whereas no specific staining was seen with 
the anti-XT3 antibody is probably antibody-specific. Indeed, the mRNA of these two 
gene products was of similar low abundance in small intestine and for both proteins we 
did not obtain any signal on Western blots of small intestine brush-border membrane, 
unlike with kidney brush border membranes where both were detected. As expected for 
proteins involved in the function of differentiated enterocytes, the signal showed a clear 
gradient along the villi, being low in the crypts and stronger towards the tips. 
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Figure 5. Localization of B0AT1, XT2, XT3 and XT3s1/SIT1 in small intestine. 
Immunohistochemistry localized three out of four transporters (B0AT1, XT2 and 
XT3s1/SIT1, red) to the brush-border membrane of intestinal villi with an axial gradient 
toward the tip. XT3 staining was not clearly visible. Anti-4F2hc antibody labels the 
basolateral membrane of intestinal epithelial cells (green) . Unlabelled spaces between 
enterocytes correspond to goblet cells. The upper row shows low and the lower row high 
magnification images. a and e, B0AT1; b and f, XT2; c and g, XT3s1/SIT1; d, XT3. The 
bars are in the upper row 40 µm and 10 µm in the lower row (e and f) and 5 µm (g). 
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 3. Regulation studies on mice challenged with modified diets 
 
3.1 High and low sodium diet treatment 
 
In 1994 Wasserman and colleagues molecularly characterized the rat homologue of 
XT2, calling it ROSIT for Renal Osmotic Stress-Induced Na+/Cl- -dependent organic 
Transproter (Wasserman et al., 1994).  It was shown, by Norhtern blot analysis, that rats 
made hypernatremic by gavage display a marked increase in ROSIT/XT2 mRNA levels 
in renal cortex, renal outer medulla and possibly in intestine. Following studies by 
Obermuller and colleagues, showed by in situ hybridization high levels of ROSIT/XT2 
mRNA in late proximal kidney tubule (S3 segment) and investigated the alteration of 
ROSIT/XT2 transcript  in response to ischemic acute tubular necrosis, as the S3 
segment is the major site of damage in the post-ischemic kidney. The study showed that 
ROSIT/XT2 mRNA levels were decreased in response to the damage (within 7 days) 
and that they were back to the normal level three weeks after ischemia (Obermuller et 
al., 1997). In 2004 Baba and colleagues investigated the localization and regulation of 
the renal osmotic-stress-induced Na-Cl organic solute cotransporter (ROSIT/XT2) 
mRNA expression by RT-PCR using microdissected nephron segments from control and 
dehydrated rats. They showed that ROSIT/XT2 mRNA was expressed predominantly in 
PST and to a lesser extent in cortical thick ascending limbs and cortical collecting ducts 
in control rats, and dehydration caused an increase in the expression in all nephron 
segments (Baba et al., 2004).  
Based on these results we decided to investigate the regulation of the expression of the 
mouse ROSIT orthologue, mXT2, and also of the other three related genes, mB0AT1, 
mXT3 and mXT3/SIT1 by real-time RT-PCR and Western blot. As described in the 
Materials and Methods section, 18 male C57BL/6J mice were divided into three groups 
and received diets with different Na+ contents. After two days, mice were sacrificed and 
kidneys harvested. Real-time RT-PCR was performed for the four B0-cluster transporter 
and both mGAPDH and mβ-actin were used for relative quantification. At first we 
evaluated the effect of Na+ on the two housekeeping genes, mGAPDH and mβ-actin, to 
make sure that no regulation would occur under these conditions (Figure  6). The 
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 analysis revealed that there is no effect on these two transcripts in the different 
conditions. 
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Figure 6. Real-time RT-PCR on mGAPDH and mβ-actin. The effect of different Na+ 
content diets was evaluated on two housekeeping gene, mGAPDH and mβ-actin. The 
graph shows that there is no effect due to the different treatments. Statistical analysis 
was performed with ONE-WAY ANOVA test with Dunnett’s multiple comparison test. 
 
The effectiveness of the short-term treatment was evaluated performing real-time RT-
PCR on the same kidney cDNAs probing mGAT2. mGAT2 (slc6a12) is the orthologue of 
rat and human BGT1 (SLC6A12). In renal epithelial cells, BGT1 is localized to the 
basolateral membrane and mediates betaine uptake and accumulation (Yamauchi et al., 
1991). The mRNA is most abundant in the medullary thick ascending limb and the inner 
medullary collecting duct (Miyai et al., 1996) and is regulated by the hydration state in 
vivo (Moeckel et al., 1997), being induced by hypertonicity. Similar observations were 
obtained from in vitro studies: BGT1 transport activity is low in renal MDCK cells 
maintained in isotonic medium but is strongly induced in response to prolonged (24h) 
hypertonic stress (Kempson, 1998; Yamauchi et al., 1991; Yamauchi et al., 1992).  
The two-days treatment of the mice was effective as shown in Figure 7. mGAT2 mRNA 
levels were indeed significantly increased (p < 0.01) in the “high Na+” condition and 
unchanged in the “low Na+” condition, compared with the “control”. 
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Figure 7. Real-time RT-PCR on mGAT2. The regulation of mGAT2 was evaluated in 
the three different conditions and the relative quantification of the transcript was 
calculated using mβ-actin as reference gene. Statistical analysis was performed with 
ONE-WAY ANOVA test with Dunnett’s multiple comparison test. Stars indicate 
significant difference versus control (P < 0.01). 
 
 
Figure 8 shows the result of the real-time RT-PCR performed on kidney mRNA of three 
mice from each group. A significant upregulation of mB0AT1 transcript induced by the 
high Na+ diet was observed while the same treatment led to a significant downregulation 
of mXT3 mRNA. The effect of the low sodium diet was to increase significantly mXT3 
and mXT3s1/SIT1 transcripts. No other significant variations could be observed, in 
particular no change in XT2 (ROSIT orthologue) mRNA level. 
The protein expression levels were analysed on kidney BBMVs (See Materials and 
Methods). For Western blotting, 20 µg of BBMVs proteins were separated on 
polyacrilamide gels and blotted on PVDF membranes. Membranes were then probed 
with mB0AT1, mXT2, mXT3 and mβ-actin antibodies. Figure 9 shows the quantification 
of each of the tested transporters relative to mβ-actin signal. Differently from what was 
observed by real-time RT-PCR at the mRNA level, no significant regulation was 
detectable at the protein level. Finally, as mentioned above, in the case of XT3s1/SIT1 
no information could be obtained since the antibody failed to recognize any specific 
band in Western blot.  
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Figure 8. Relative mRNA abundance of mB0AT1, mXT2, mXT3 and mXT3s1/SIT1. 
The abundance of mRNAs was measured by Taq Man® real time RT-PCR and the level 
of the tested transporter mRNAs relative to that of mβ-actin is indicated for each 
condition. Significant upregulation of the mB0AT1 transcript was found in response to 
high sodium content diet treatment while a downregulation was observed for the mXT3 
transcript in the same condition. The low sodium content diet resulted in significant 
upregulation of the mXT3 and the mXT3s1/SIT1 transcripts.  
The color code is the same as in Figure 6 and 7. 
ONE-WAY ANOVA test with Dunnett’s multiple comparison test. Stars indicate 
significant difference versus control (P < 0.01). 
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Figure 9. Relative protein abundance of mB0AT1, mXT2 and mXT3. The abundance 
of the transporter proteins was estimated by Western blotting relative to the mβ-actin 
signal.  No significant regulation was detected for the different conditions for any 
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 transporter. mXT3s1/SIT1 could not be quantitated due to the lack of reactivity of the 
antibody on Western blots. Statistical analysis was performed with ONE-WAY ANOVA 
and using Dunnett’s multiple comparison test. 
 
The different results obtained with the two techniques are probably due to intrinsic 
characteristics of quantifying mRNA levels versus protein. Real-time RT-PCR is 
extremely precise and reliable when compared to manual quantification of Western blot. 
In addition, there is no constant relationship between mRNA levels, protein production 
and protein pool and furthermore BBMVs proteins represent only a part of the cellular 
protein content whereas the mRNA was from total kidney. Thus it appears that the 
changes in some transporter mRNA levels induced by different salt diets do not translate 
into changes in protein luminal cell surface expression. 
 
3.2 Induction of metabolic acidosis and alkalosis 
 
The mammalian proximal tubule reabsorbs 75-90% of the filtered HCO3-. This 
reabsorptive process involves luminal and basolateral transport, both of which may 
require Na ions. Na+-dependent acid-base transporters include 1) a luminal Na+-H+ 
exchanger that is inhibited by amiloride (NHE-3 in kidney) and 2) a basolateral 
electrogenic Na+/HCO3- cotransporter (NBC) that is sensitive to the blocking action of 
disulfonic stilbene derivatives (Geibel et al., 1989). The electrogenic Na+/HCO3- 
cotransporter (symporter) is the major HCO3- transporter of the renal proximal tubule 
and also plays a noteworthy role in Na+ reabsorption (Boron et al., 1997).  
During chronic metabolic acidosis (CMA), the plasma levels of glutamine are increased 
and so is glutamine metabolism in the kidney tubule cells. Degradation of glutamine 
results in the formation of ammonium (NH4+) and bicarbonate (HCO3-) ions, which are 
excreted into the pre-urine and transported to the peritubular blood, respectively. This 
process contributes to counteract acidosis and to restore normal pH.  
Glutamine transport plays and important role both for the generation of ammonia that is 
used for protein excretion and for that of bicarbonate. Edwards’ group molecularly 
identified a protein, SN1 (SNAT3, SLC38A3), corresponding to the neutral amino acid 
transport system N (Chaudhry et al., 1999; Palacin et al., 1998) and thus mediates Na+-
dependent glutamine transport. SNAT3 is localized in astrocytes in the brain and retina, 
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 liver, kidney and adipose tissue (Mackenzie and Erickson, 2004). It has recently been 
shown to be expressed basolaterally in proximal kidney tubule and to be strongly 
induced in acidosis (Solbu et al., 2005) (Moret et al., in preparation). 
Glutamine is also one of the favourite B0AT1 substrates (Bohmer et al., 2005; Camargo 
et al., 2005). To investigate the possible contribution of B0AT1 and related transporters 
in amino acid and in particular glutamine cellular import during metabolic acidosis and 
alkalosis, we submitted mice to acidosis and alkalosis by supplying 0.28 M NH4Cl and 
0.28 M NaHCO3 in the drinking water, respectively, for 7 days. Then mice were 
sacrificed and kidney harvested to analyze the mRNA and protein content. Figure 10 
shows the expected upregulation of mSNAT3 transcript by real-time RT-PCR in mice 
having metabolic acidosis, a result that validates our treatment. The increase is about 6-
fold compared to control mice while there is no effect of metabolic alkalosis on mRNA 
levels of treated mice. 
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Figure 10. Real-time RT-PCR of mSNAT3 mRNA. The regulation of mSNAT3 mRNA 
was evaluated in the three different conditions and the relative quantification of the 
transcript was calculated using mβ-actin as reference gene. A 6-fold increase in the 
mSNAT3 transcript was observed. Statistical analysis was performed with ONE-WAY 
ANOVA test with Dunnett’s multiple comparison test. Stars indicate the statistical 
significance of the difference relative to the control (P < 0.01). 
 
The mRNA abundance of mB0AT1 and related transporters is shown in Figure 11.  A 
statistically significant downregulation of B0AT1 mRNA was observed in animals 
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 receiving NH4Cl in the drinking water. A small decrease in the transcript levels of mXT2 
and mXT3s1/SIT1 was observed in mice that developed metabolic alkalosis and an 
increase in mXT3s1/SIT1 mRNA in acidotic mice. No significant effect was observed for 
the mXT3 transcript in either condition. 
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Figure 11. Relative mRNA abundance of mB0AT1, mXT2, mXT3 and mXT3s1/SIT1. 
The abundance of mRNAs was measured by real time RT-PCR and the level of the 
tested transporter mRNAs relative to that of mβ-actin is indicated for each condition. A 
statistically significant downregulation of the mB0AT1 and the mXT3s1/SIT1 transcripts 
was found in response to metabolic acidosis and for the mXT2 and the mXT3s1/SIT1 
transcripts during metabolic alkalosis. No significant variations were observed for mXT3 
in both conditions. Statistical analysis was performed with ONE-WAY ANOVA test with 
Dunnett’s multiple comparison test. Stars indicate a statistically significant change 
versus control (P < 0.05). 
The colour code is the same as in Figure 10. 
 
The relative abundance of the transporter protein expressed in the luminal brush border 
was also evaluated and the results are shown in Figure 12. To perform Western blotting 
20 µg of kidney BBMVs were separated on SDS-PAGE and transferred onto PVDF 
membranes that were then incubated with antibodies directed against mB0AT1, mXT2 
and mXT3. Anti-mβ-actin antibody was used as reference to evaluate the relative 
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 abundance of these B0-cluster transporters. As in the case of the Western blot shown in 
Figure 9, no significant differences were observed for the different transporters in treated 
and non-treated mice. As in the case of the different Na+ diets the reason could be the 
different sensitivity of the two techniques as well as the material used. 
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Figure 12. Relative protein abundance of mB0AT1, mXT2 and mXT3. The 
abundance of proteins was measured by Western blotting relative to mβ-actin signal.  
No significant regulation was detected for the different conditions and transporters. It 
was not possible to make the evaluation for mXT3s1/SIT1 due to lack of reactivity of the 
antibody in Western blotting. Statistical analysis was performed with ONE-WAY ANOVA 
test with Dunnett’s multiple comparison test. 
 
 
4. XT3 knockout mice generation 
 
Functional investigations of the XTs were initially pursued with different in vitro models, 
such as mammalian cells and Xenopus laevis oocytes. Focusing on mXT2 and mXT3 
these studies failed to elucidate their function. Therefore, we tought to use a different 
approach, creating a knockout mouse for XT3. 
The mouse XT3 gene is located on chromosome 9, extends over about 40 kb and it is 
constituted by 11 exons and 10 introns. Analyzing the gene sequence of mXT3 available 
three years ago, we immediately had to exclude from the targeting vector plans the use 
of the intronic sequence between the first and the second exon due to long stretches of 
unknown sequence. The strategy that we then followed for the construction of the 
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 targeting vector to be used for the transfection of the embryonic stem cells has been 
already described in the Materials and Methods section. 
As mentioned, the PCR amplification of the long sequence located between exons 6 and 
8 first required much technical adaptation and then the fragment resisted multiple 
attempts of cloning into the targeting vector. Therefore and also because this first 
member of the SLC6 cluster of interest SLC6A19, was identified and characterized as B0 
transporter (Broer et al., 2004), we decided to provisionally discontinue this project. We 
then focused on a XT2 knockout mouse obtained from M. Caron that is being currently 
backcrossed and characterized by D. Singer, a new PhD student of our lab. 
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 DISCUSSION 
 
1. Expression of mXT3 in Opossum Kidney cells 
 
Functional characterization of the B0-cluster transporters mXT3 and mXT2 was first 
attempted in mammalian cell lines and Xenopus laevis oocytes. Their expression in 
oocytes and in several mammalian cell lines resulted in no induced amino acid transport 
due to lack of surface expression. The only cell line showing apical surface expression 
for mXT2 and mXT3 was the Opossum kidney (OK) cell line, from which we later cloned 
the ortholog genes for XT3, XT2 and B0AT1 (Ristic et al., 2005). Focusing on XT3, we 
produced a stably transfected cell line, hypothesising that the presence of the 
transporter at the apical surface would allow its functional characterization. Despite the 
apical localization of mXT3, stably transfected OK cells were not a useful tool for the 
investigation of the transport characteristics of mXT3, as the transport measured in cells 
expressing the exogenous transporter was not significantly different from the transport 
expressed endogenously in wild type cells. The difficulty of differentiating mXT3-induced 
transport from the overall transport measured in these cells could be due to several 
reasons. For instance the complexity of an intact cell system with its pool of amino acid 
transporters possibly having overlapping substrates with the transporter of interest. 
Moreover, the expression level of the exogenous transporter might be not enough to be 
distinguished from the total transport measured and/or might be masked by the 
endogenous XT3 transporter.  
Hypothesising that mXT3 could be a B0-type transporter, we decided to first investigate 
the B0-type neutral amino acid uptake in wild type OK cells. Using this approach we 
could demonstrate that OK cell monolayers display a B0-type Na+- dependent neutral 
amino acid transport which is suggested to be mediated by more than one B0-like 
transporter. Moreover, hybrid depletion and RNA silencing experiments showed that the 
opossum orthologue of human and mouse SIT1, oSIT1, plays a major role for the Na+-
dependent apical uptake of neutral amino acids in OK cells (Ristic et al., 2005). 
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 2. B0-cluster transporter in kidney and small intestine 
 
2.1 B0AT-related transporters in human and in mice 
 
As described in the Introduction section (4.3), the majority of the members in the SLC6 
family mediate the translocation of neurotransmitters across the cell membrane and 
fewer are involved in amino acid uptake, such as B0AT1 and its related transporters, 
which form a separate cluster. In human, the cluster has three members while in mouse 
there is an additional one.   
XT2 and B0AT1 genes are organized in tandem on chromosome 5p15 in human, the 
locus where the Hartnup disorder has been mapped (Kleta et al., 2004; Seow et al., 
2004). In mouse, these genes are located on chromosome 13 in a region, which is 
synthenic to human 5p15. The two mouse proteins have a degree of identity of about 
50%. 
In human, there is a single XT3 gene (SLC6A20) located on chromosome 3p21.3 for 
which two splice variants have been detected. Surprisingly, the brain-specific isoform is 
predicted to lack one of the 12 putative transmembrane domains, whereas the isoform 
expressed in kidney has an overall domain structure similar to B0AT1 (Kiss et al., 2001). 
In mouse and in rat, there are two corresponding genes organized in tandem on 
chromosome 9, XT3 and XT3s1, the latter encoding XT3s1/SIT1 (Takanaga et al., 
2005). The identity between XT3 and XT3s1/SIT1 proteins is 90%, with complete identity 
over long stretches and large differences only in the NH2- and COOH- termini. 
XT3s1/SIT1 shares a higher degree of identity (91%) with human XT3 compared with 
mouse XT3 that is only 86% identical. It appears thus that the mouse XT3 gene is the 
product of a relatively recent duplication and that mouse XT3s1/SIT1 more closely 
resembles human XT3 (Kiss et al., 2002). 
Our localization data suggest that mouse XT3s1/SIT1 has a broader expression pattern 
than mouse XT3. Similarly, EST databases reveal that rat SIT1 is also widely-
distributed, as pointed out in the publication on rat SIT1 (Takanaga et al., 2005). This rat 
gene, previously referred to as XT3 or rB21a, is in reality the orthologue of mouse 
XT3s1/SIT1 (Takanaga et al., 2005). In situ hybridization in mouse and in rat did not 
70 
 distinguish between the two gene products and revealed their localization in brain, 
kidney and small intestine (Kowalczuk et al., 2005; Takanaga et al., 2005).  
 
2.2 Tissue localization of the B0AT-cluster transporters 
 
The B0AT-cluster transporters are mainly expressed in tissues that contain epithelia. 
They are all abundantly expressed in kidney and they are also present in small intestine 
where B0AT1 and XT3s1/SIT1 mRNAs are 100- to 1000-fold more abundant than those 
of XT2 and XT3. Immunofluorescence experiments in kidney and small intestine show 
that all four transporters localize to the brush border membrane of epithelial cells, a 
localization that is compatible with a role in apical uptake of solutes, for instance amino 
acids in the case of B0AT1 and imino acids in the case of XT3s1/SIT1. This localization 
agrees with the known function of B0AT1 that is defective in Hartnup disorder (Broer et 
al., 2004; Kleta et al., 2004; Seow et al., 2004) and with that of XT3s1/SIT1 that was 
shown in Xenopus laevis oocytes to mediate a transport corresponding to that of brush 
border imino system (Kowalczuk et al., 2005; Takanaga et al., 2005). It is noteworthy 
that the two other luminal transporters did not produce, in the same expression 
conditions, any reproducible amino acid transport. Interestingly, these transporters (XT2 
and XT3) appeared on immunofluorescence images not to localize to the surface of 
Xenopus laevis oocytes (data not shown). From their high level of similarity with B0AT1 
and XT3s1/SIT1 respectively, one can suggest the hypothesis that XT2 and XT3 might 
exert similar but complementary functions.  
 
2.3 Differential localization of the B0AT-cluster transporters along the kidney proximal 
tubule and in small intestine 
 
B0AT1 localizes to the early part of the proximal tubule (S1 and S2 segments), very 
similarly to b0,+AT1, the catalytic subunit of the apical cystinuria transporter, and to the 
basolateral heterodimeric transporters y+LAT1- and LAT2-4F2hc that are known to play 
an important role in the basolateral export of amino acids (Bauch et al., 2003; Borsani et 
al., 1999; Dave et al., 2004; Fernandez et al., 2002; Pfeiffer et al., 1999; Torrents et al., 
1999; Verrey et al., 2004). The common S1-S2 localization of these transporters 
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 suggests that they are part of high capacity amino acid transport machinery. In contrast, 
XT2, the "tandem" transporter of B0AT1, localizes also to the brush border membrane of 
the proximal tubule, but with a complementary axial distribution, namely mainly in S3, 
the late segment of the proximal tubule. This differential and complementary axial 
localization of related transporters along the proximal tubule resembles that of the two 
sodium-glucose co-transporters (SGLT1 and -2) and of the two proton-driven peptide 
transporters (PEPT1 and -2) where in both cases the low affinity form localizes to the 
early part and the high affinity form to the late part of the proximal tubule (Kanai et al., 
1994; Leibach and Ganapathy, 1996; Liang et al., 1995; Pajor et al., 1992; Poppe et al., 
1997; Shen et al., 1999; You et al., 1995). As in these cases, B0AT1 that localizes to the 
early part of the proximal tubule displays a relatively low apparent affinity with a K0.5 of 
around 1 mM for its best amino acid substrates (Camargo et al., 2005). However, the 
function of its potentially “complementary” transporter XT2 is not yet clear, although it 
has been suggested based on the characterization of a knock out mouse that it is a high 
affinity glycine transporter (Quan et al., 2004). Interestingly, from these two transporters, 
it is the low affinity B0AT1 that is more abundant in small intestine, similar to the situation 
of PEPT1 (Leibach and Ganapathy, 1996). 
In contrast, the axial distribution of the ”tandem” transporters XT3s1/SIT1 and XT3 
overlaps entirely along the kidney proximal tubule whereas in small intestine, only 
XT3s1/SIT1 is strongly expressed, both at the mRNA and protein levels. The localization 
the of XT3s1/SIT1 mRNA in the pia mater and plexus choroideus suggests that this 
transporter is also involved in L-proline transport in and out of the brain (Kowalczuk et 
al., 2005).  
 
3. Dietary regulation of B0-cluster transporters 
 
3.1 Lack of major regulation of B0-cluster transporters by Na+ load or deprivation 
 
In vivo studies on rats showed that ROSIT/XT2 is regulated by changes in sodium intake 
as a function of changes in the body fluid osmolarity (Baba et al., 2004; Obermuller et 
al., 1997).  
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 Based on these observations, we hypothesised that the expression of ROSIT/XT2 
mouse ortholog, mXT2 (SLc6a18), could be also affected in response to sodium load. In 
addition, we decided to extend our investigation to the other B0-related genes, B0AT1, 
XT3 and XT3s1/SIT1 and to treat mice with a sodium free diet. Mice treated with two 
different sodium content diets resulted in small mRNA variations of the four transporters 
but no change could be detected by Western blot analysis of the luminal cell surface 
proteins. The effectiveness of our treatment was confirmed by the analysis of the GAT2 
(Slc6a12) mRNA level which was significantly upregulated in response to high salt diet, 
as expected. 
Taken together these data show only a mild regulation of B0-cluster transporters at the 
mRNA level by these treatments. Moreover, we could show that mXT2, in contrast to the 
results published for rat ROSIT/XT2, is apparently not osmotic-stress inducible, at least 
not by the high salt treatment that significantly upregulated GAT2 transporter mRNA. In 
drawing our conclusions, we need to consider that the gavage treatment for making the 
rats hypernatremic and our diet with high salt content given to mice are not identical and 
that this difference could explain the lack of mXT2 regulation in our study. 
 
3.2 Lack of major regulatory effect of metabolic acidosis and alkalosis on B0AT-related 
transporters 
 
During metabolic acidosis, the Na+-dependent glutamine transporter (SNAT3) is 
upregulated to increase the glutamine metabolism, leading to the production of more 
ammonium and bicarbonate (HCO3-).  Bicarbonate transport to the peritubular blood 
counteracts acidosis and thereby helps maintaining the physiologically slightly alkaline 
blood pH (7.4).  
Several transport systems can transport glutamine across plasma membranes. 
However, many of these systems either are not expressed in the kidney or are obligatory 
exchangers and thus unable to perform net translocation of amino acids across the 
plasma membrane (Chaudhry et al., 2002; Palacin et al., 1998). From the B0-cluster 
transporters, B0AT1 is known to transport glutamine (Bohmer et al., 2005; Camargo et 
al., 2005). Therefore we asked whether it was upregulated by acidosis similarly to SN1, 
that was shown in rats submitted to chronic metabolic acidosis to be increased five- to 
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 six-fold in cortical tubule in parallel with the phosphate-activated glutaminase, a 
mitochondrial enzyme involved in ammoniagenesis (Solbu et al., 2005).  
Our study in mice shows that induction of metabolic acidosis results in more than 4-fold 
increase in SNAT3 mRNA but has no major effects on the B0AT-related transporter 
mRNAs, except for a slight downregulation of B0AT1 and a mild upregulation of the 
mXT3s1/SIT1 transcript. Similarly, no regulation was observed during metabolic 
alkalosis. 
Western blot analysis on the luminal cell surface proteins did not show any effect in both 
conditions. 
Taken together our data suggest that B0-cluster transporters are not sensitive to 
changes in the acid-base state, being expressed at similar levels in the different 
conditions tested. 
 
4. Conclusions  
 
The transporters B0AT1, XT2, XT3 and XT3s1/SIT1 form a phylogenetic cluster within 
the SLC6 family. Besides their protein sequence similarity, they share brush-border 
localization in the proximal kidney tubule and are, as shown for B0AT1 and XT3s1/SIT1, 
Na+-dependent transporters of amino/imino acids. From this group of transporters, the 
two functionally characterized members are also the ones highly expressed in small 
intestine. All tissues expressing B0AT-cluster members, with the exception of spleen, 
serve trans-epithelial/endothelial transport functions. Thus, the localization and the 
structural similarity of the pairs B0AT-XT2 and XT3s1/SIT1-XT3 together suggest that 
the orphan transporters XT2 and mouse XT3 possibly exert epithelial amino- and 
imino(amino) acid transports which could be complementary to the function of B0AT1 
and XT3s1/SIT1, respectively. 
Moreover, in vivo studies demonstrated that B0AT-related transporters are only very 
mildly regulated by treatments that alter body fluid osmolarity and acid-base balance 
suggesting that they are constitutive elements of the proximal tubule reabsorption 
machinery and thus not involved primarily in providing substrates for metabolic tasks of 
these epithelial cells. 
 
74 
 5. Future perspectives 
 
The results presented in this PhD thesis contribute to the understanding of tissue 
localization and in vivo regulation of four mouse proteins belonging to the Slc6 family. 
Up to date only two of them, B0AT1 and SIT1, have been functionally characterized 
while for XT2 a knock-out mouse is available and currently being investigated in our 
laboratory.  
This characterization of the phenotype of the XT2 knock-out mouse that will include 
analysis of the amino acid levels in urine and blood could shed light on the function of 
this transporter in kidney. Moreover, using telemetric blood pressure measurements, we 
will investigate the functional role for XT2 in blood pressure control. Indeed, such an 
effect has been suggested by Caron’s study in which XT2 knock out mice were shown to 
have an elevated blood pressure (Quan et al., 2004). Because XT2 knock out mice had 
shown in this study only a mild renal phenotype, this will be further analyzed by 
challenging them with high and low protein diets that might reveal more clearly transport 
defects. Additionally, since the mildness of the phenotype could be the result of 
compensatory mechanisms as for instance an increased expression of one or more 
other B0-cluster transporters also localized in the late proximal tubule, real-time RT PCR 
and Western blot analysis could be used to test their expression levels in XT2 knock out 
mice compared to wild type animals. 
As proposed for XT2, also the function of XT3 could be discovered using a knock out 
mouse. The finalization of the targeting vector I partially constructed could be the first 
step for the production of such a mouse model lacking XT3. The resulting phenotype 
could then be analysed using similar methods as described for the XT2 knock out 
mouse.  
Finally, elucidating the function of XT2 and XT3 will clarify the role of these transport 
proteins for the reabsorption of amino acids in the kidney proximal tubule and will help to 
understand the differential localization of these proteins along the tubule that was 
observed by immunohistochemistry. 
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ADDENDUM 
 
 
 
 
Project: Physiological role of 2-P-domain K+ channels: Phenotypic analysis of the 
TASK2 knockout mouse. 
 
 
Supervisor: Prof. Dr. Richard Warth, University of Regensburg, Germany 
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 1. INTRODUCTION 
 
1.1 The potassium channel family 
 
Potassium channels are protein complexes that form K+-selective pores in biological 
membranes, allowing the passive transport of K+ through membranes. They play a major 
role in the control of K+ homeostasis and cell volume but also in physiological functions 
that are associated with modifications of the electrical membrane potential such as 
neurotransmitters and hormone secretion and neuronal and muscular excitability. A wide 
variety of K+ currents have been recorded in native tissues that can be distinguished 
according to their functional and pharmacological properties. In the last 15 years many 
K+ channels have been cloned and characterized in expression systems. Since 1998 the 
structures of five different prokaryotic K+ channels have been determined by x-ray 
crystallography, including KcsA (Doyle et al., 1998; Zhou et al., 2001), MthK (Jiang et al., 
2003) (a Ca2+-gated K+ channel), KirBac (Kuo et al., 2003)  (an inward-rectifier K+ 
channel), KvAP (Jiang et al., 2003) (a voltage-dependent K+ channel) and Kv1.2 K+ (a 
voltage-dependent K+ channel with its ß2 subunit) (Long et al., 2005; Long et al., 2005). 
They are multimers of hydrophobic subunits that form the ionic pore itself, often 
associated with accessory subunits (for review, see Refs. (Coetzee et al., 1999; Jan and 
Jan, 1997)). More than 60 pore-forming subunits have now been cloned in mammals. 
They are classified into three groups according to their membrane topology (Figure 1) 
(Buckingham et al., 2005). The largest group comprises subunits that contain a 
hydrophobic core with six transmembrane segments (6TMS) and one pore (1P) domain 
(figure 1c). This domain is directly involved in the formation of the selectivity filter that 
provides the specificity for K+ transport. The second family is formed by pore-forming 
subunits having only 2TMS and 1P domain (Figure 1a). The extensive characterization 
of these two types of cloned subunits both in vitro and in vivo, as well as the isolation of 
associated regulatory subunits, has allowed the reconstitution of many different types of 
K+ channels such as voltage-gated K+ channels, Ca2+-dependent K+ channels, ATP-
sensitive K+ channels, G protein-coupled K+ channels, and inward rectifiers.  
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 The last group of K+-selective pore-forming subunits corresponds to proteins with 4TMS 
and 2P domains, instead of one as for the other K+ channel families (Figure 1b). This 
unique feature is at the origin of their name, 2P domain K+ channels or K2P channels.  
 
1.2 Two-pore-domains channels 
  
The first mammalian member of the two-pore-domains channel family was identified in 
1996 and named TWIK1 (Tandem of P-domains in a weak inwardly rectifying K+ 
channel) (Lesage et al., 1996). Fourteen other family members are now identified and 
subclassified based on their sensitivity to fatty acids, stretch, or protons (Lesage, 2003). 
According to the classification proposed by Buckingham the two-pore-domain channels 
can be subdivided into five functionally distinct groups: TWIK-like channels, stretch-
activated TREK-like channels (TWIK-related K+ Channel), TRAAK-like channels (TWIK-
related arachidonic acid stimulated K+ channel) activated by polyunsaturated fatty acids, 
acid-sensitive TASK1-like channels (TWIK-related acid-sensitive K+ channels), and 
TRESK (TWIK-related spinal cord K+ channel) (Buckingham et al., 2005; Lesage et al., 
1996; Lesage and Lazdunski, 2000; Sano et al., 2003).  
 
 
Figure 1. The topology of the transmembrane (TM) and pore-forming (P) domains of the 
three main classes of K+ channels in animals: (a) inward rectifier channels, which 
contain two TM domains and one P domain; (b) two-pore-domain channels, which 
contain four TM domains and two P domains; and (c) SHAKER-like, voltage-gated K+ 
channels, which contain six TM domains and one P domain. From (Buckingham et al., 
2005) 
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 1.2.1 TASK-2 
 
TASK-2 was isolated from human kidney and its gene was mapped to chromosome 
6p21 (Reyes et al., 1998). It is expressed in various epithelial tissues including the 
pancreas, placenta, lung, small intestine, colon, and at highest levels in kidney (Reyes et 
al., 1998; Warth et al., 2004). This is in contrast to TASK-1 and TASK-3 channels, which 
are mainly expressed in the CNS (Reyes et al., 1998). Moreover, immunolabeling for 
TASK-2 was observed in rat carotid bodies, peripheral chemoreceptive organs, which 
express also other 2P K+ channels (Kummer and Yamamoto, 2002; Yamamoto et al., 
2002).  
TASK channels are sensitive to extracellular pH, the channel currents are maximal at 
alkaline pH and progressively inhibited as pH decreases: e.g. TASK-2 displays 90% of 
its maximal current at pH 8.8 but only 10% at pH 6.5 (Reyes et al., 1998).  Moreover, 
TASK-2 currents are sensitive to anaesthetics, being inhibited by lidocaine and 
bupivacaine and activated by halothane and chloroform (Reyes et al., 1998). 
My experiments contributed to the characterization of a TASK-2 knockout mouse model 
that has been created by K. Mitchell via disruption of the TASK-2 gene by a vector 
containing the genes for lacZ/neo and placental alkaline phosphatase (PLAP) (Mitchell 
et al., 2001). In particular, the respiratory and the renal phenotypes have been 
investigated using the following Materials and Methods. 
 
2. MATERIALS AND METHODS 
 
2.1 Genotyping  
 
Tail biopsies were digested and treated as described in the Material and Method section 
of the main doctoral thesis. To localize the precise site of insertion of the secretory-trap 
vector into the TASK-2 gene I designed several primer pairs including the gene region of 
intron 1. PCR has been performed using different DNA polymerases: Advantage-GC 
Genomic Polymerase (BD Bioscience, Belgium), Advantage HF Polymerase (BD 
Bioscience, Belgium), EurobioTaq polymerase (Eurobio, France) and Pfu Turbo DNA 
Polymerase (Stratagene, La Jolla, CA, USA), using the buffers supplied and following 
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 the protocol optimized by the company (including cycler conditions), in presence of 0.5 
µM each primers (oligonucleotides) and 0.2 mM each dNTPs.  Therefore, a real time 
PCR strategy to genotype TASK2 mice has been designed. Real time PCR has been 
performed with the same procedures described in the Material and Method section of 
the main doctoral thesis. The sequences of primers and probe used are: sense primer 
5’- CCATTCGACCACCAAGCG-3’; antisense primer 5’- AAGACCGGCTTCCATCCG-3’; 
internal probe 5’- AACATCGCATCGAGCGAGCACGTA-3’ labelled with reporter dye 
FAM at the 5’ end and the quencher dye TAMRA at the 3’ end (Microsynth, Balgach, 
Switzerland). 
The primers used for the PCR to exclude the insertion in the intron 2-3 are: sense primer 
on exon 2 5'-CACAGTCATCACCACCATCG-3'; antisense primer on exon 3 5'-
TAGAAGACACAGAAGAGGCGC-3'. 
 
 
2.2  X-Gal Staining 
 
Anesthetized mice were perfused via the left ventricle with 10 ml of heparinized 0.9% 
NaCl solution at 37°C and subsequently 50 ml of 3% paraformaldehyde solution at 37°C 
and pH 7.4. Cryosections of kidneys (10 and 20 µm) were stained overnight at 37°C in 
the following mixture: 0.1 M phosphate buffer, X-gal (5-Bromo-4-chloro-3-indolyl β-D-
Galactoside)1 mg/ml, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and 2 
mM MgCl2.  
The targeting vector produced by Mitchell and colleagues encodes a β-
galactosidase/neomycin-resistance fusion protein (β-geo) with a membrane-spanning 
domain. Both enzymatic activities of the fusion protein (resistance to neomycin and β-
galactosidase activity) are only achieved when the transgene inserts within a gene that 
provides a secretory signal. In our case, the β-galactosidase (β-gal) is inserted in the 
TASK-2 gene and therefore is under its promoter. In TASK-2 knockout mice β-gal 
cleaves the X-gal glycosidic linkage in cells where TASK-2 promoter is active, such as 
proximal tubule cells, producing a soluble, colourless indoxyl monomer. Subsequently, 
two of the liberated indoxyl moieties form a dimer, which is non-enzymatically oxidized. 
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 The resultant halogenated indigo is a very stable and insoluble blue compound. The 
ferricyanide and ferrocyanide form a blue precipitate (Prussian blue) upon reaction with 
free ferric ion which is soluble only in organic solvents and does not diffuse during the 
staining procedure. Wild type tissue is also stained in parallel to set the background due 
to the endogenous lysozomal β-gal present in all tissues. Its pH optimum is very low, 
and thus it is not very active in the pH 7.5-7.6 of the buffer used for the staining. 
 
2.3  Plethysmographic measurements 
 
Respiratory function was studied using whole body plethysmography on TASK-2 
knockout mice (EMKA Technologies, France) (Figure 2). In contrast to “true” 
plethysmography, ventilation parameters are not measured as gas volumes by this 
setup but calculated from pressure changes after a calibration procedure. The important 
advantage of the device is the possibility of measuring respiratory parameters in non-
anesthetized, unrestrained mice. Several respiratory parameters could be recorded from 
wild-type and knockout mice using iox software (EMKA Technologies, France). 
Figure 2. Whole body plethysmography. Four mice can be tested in parallel. On the 
right-hand side the respiratory parameters recorded by the software are depicted.  
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 3. RESULTS 
 
3.1 Genotyping of TASK-2 mice 
 
The generation of TASK-2-/- mice was performed using a modified gene-trapping 
strategy that allows the isolation of insertional mutations specifically in secreted and 
membrane-spanning protein (Mitchell et al., 2001). By this technique the precise site of 
insertion of the secretory-trap vector into the target gene is not known. For that reason, 
such knockout mice have to be genotyped by neomycin-specific dot-blot. In principle, 
this technique works also for TASK-2-mice, but often it is difficult to distinguish between 
heterozygous and homozygous mice. Thus, this part of my project was aimed at 
establishing a PCR-based genotyping protocol which allows to clearly distinguishing 
heterozygous from homozygous mice. Dr. Mitchell suggested that the point of vector 
insertion is located in intron 2. Therefore, I tested several primer pairs in order to find a 
strategy for PCR-based genotyping of TASK2 mice using forward primers on exon 2. 
Unfortunately, I could not find such primers and, in addition, I could rule out an insertion 
of the targeting vector into intron 2 (Figure 3b). My data clearly indicate that the point of 
insertion is in the intron 1 which comprises around 30 kb and several CG-rich and 
repeats-containing regions (Figure 3a). Unfortunately, I could not precisely localize the 
point of insertion of the vector probably because of the large size of intron 1 and its 
“PCR-resistant” sequences. Therefore, I have established real-time PCR to genotype 
newborn mice by assessing the amount of a neomycin-specific amplicon.  
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Figure 3. PCR-based genotyping of TASK-2 knockout mice. a. drawing of the TASK-
2 gene on Chromosome 14 showing the arrangement of exons and introns. Intron sizes 
are indicated. P, primers. b. PCR product of the two primers depicted in the drawing on 
exons 2 and 3 using as template TASK-2+/+ and TASK-2-/- genomic DNA. The identical 
band in both reactions demonstrate that the targeting vector is not inserted in the intron 
2-3. 
 
 
3.2  Localization of TASK-2 
 
Expression analysis of TASK-2 by Northern blot and PCR indicated a very strong 
expression of this channel in the kidney, however, the precise distribution along the 
nephron was not clear (Reyes et al., 1998). I used the lacZ gene insertion by the 
knockout vector to visualize cells with an activated TASK-2 promotor via X-gal 
coloration. In kidney kryo-sections of TASK-2 +/- a strong X-gal staining was found in 
proximal tubules (Figure 4) and in papillary collecting ducts. Sections from wild-type 
animals did not show such a staining. 
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Figure 4. TASK-2 localization along the nephron. X-gal staining was performed on a 
20 µm thick whole kidney section of a TASK-2 +/- mouse. Strong staining was found in 
convoluted and straight proximal tubules (1) and in papillary collecting ducts (2). Higher 
magnification pictures of respective areas are shown in inserts (Warth et al., 2004). 
 
3.3  Plethysmographic measurements 
 
In order to investigate the physiological role of TASK-2 in the regulation of ventilation, 
we used TASK-2 knockout mice for whole body plethysmographic measurements. 
Several respiratory parameters were recorded from wild-type and knockout mice. 
In plethysmographic experiments, we found significant differences in the respiration 
pattern of TASK-2 knockout mice in comparison with wild-type animals. Hypoxic 
conditions were generated into the chambers by reducing the percentage of oxygen 
from 21 to 6, replacing the oxygen with nitrogen. The mice were kept in this condition for 
15 minutes and the respiratory parameters were registered. 
The knockouts were not able to cope with the oxygen reduction. This suggests a role of 
TASK-2 in the regulation of the respiration (Figure 5). 
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Figure 5. Plethysmography on TASK-2+/+ and TASK-2-/- mice. Minute volume 
recording from different mice (for every mouse a different color) during hypoxia 
experiments. Wild-type mice are shown in the upper panel, TASK-2 knockouts in the 
lower one. The stars indicate the points where animals stopped breathing. 
 
 
4. DISCUSSION 
 
4.1 TASK2 targeting vector is inserted in intron 1 
 
The secretory-trap vector produced by Mitchell and colleagues allows the access to all 
classes of proteins targeted to the secretory pathway and the insertions in these genes 
can be efficiently transmitted to the germ line (Mitchell et al., 2001).  The genotyping 
strategy used by Mitchell and colleagues was based on dot-blot hybridization of tail 
biopsies (Brennan and Skarnes, 1999; Mitchell et al., 2001). We decided to use a 
different approach, designing specific primers for the PCR-based genotyping analysis. 
Firstly, we needed to identify the exact targeting vector insertion site. After excluding the 
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 insertion in the intron 2-3 (Figure 3) we focused on the intron between exons 1 and 2 
where the vector could have been inserted. The technical difficulties due to this intronic 
sequence lead us to modify our genotyping strategy quantifying by real time PCR the 
relative amount of the neomycin-resistance gene. This approach led to the successful 
screening of TASK-2 knockout mice.
 
4.2 TASK-2 localizes to proximal tubules and collecting ducts in mouse kidney  
 
Reyes and colleagues showed by Northern blot and RT-PCR analyses that the TASK-2 
message is poorly expressed or absent in the nervous and muscular systems but it is 
present in epithelial tissues, such as lung, colon, intestine, stomach, liver, and 
particularly in the kidney (Reyes et al., 1998; Warth et al., 2004). The distribution of 
TASK-2 within kidney cortex was examined by in situ hybridization, suggesting that the 
expression of TASK-2 is restricted to the cortical distal tubules and the collecting ducts 
(Reyes et al., 1998). In these structures, K+-selective currents have been postulated to 
play a major role in the volume regulation and in the control of the negative potential of 
tubule cells, in the K+ recycling across the basolateral membranes in conjunction with 
the Na-K-ATPase, and in the K+ secretion into the tubular lumen in concert with Na+ 
influx through amiloride-sensitive Na+ channels (for reviews, see (Giebisch, 1998; Wang 
et al., 1997).  
In contrast to the observations of Reyes and colleagues, our localization study on kidney 
sections from TASK-2+/- mice showed that the task-2 promoter-driven X-gal staining is 
present all along the proximal tubule and in papillary collecting ducts but not in cortical 
distal tubules or cortical collecting ducts (Warth et al., 2004). Together with our French 
collaborators, we have investigated the functional role of TASK-2 in the kidney. Patch-
clamp experiments (performed by P. Poujeol) on proximal tubular cells isolated from 
wild-type and TASK-2-/- knockout mice showed that TASK-2-mediated K+-conductance 
is activated during the basolateral transport of NaHCO3 because extracellular HCO3- 
stimulated pH-sensitive TASK-2. By this mechanism, TASK-2 channels hyperpolarize 
the basolateral membrane thereby supporting further electrogenic NaHCO3 export. To 
test the physiological significance of these in vitro data, we performed a series of in vivo 
experiments using the TASK-2 knockout mouse. TASK-2-/- mice when challenged with 
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 high NaHCO3 load displayed impaired Na+ and water handling due to defects in proximal 
tubular NaHCO3 reabsorption. Moreover, under control conditions TASK-2 knockout 
mice had higher urinary pH and HCO3- excretion leading to slight metabolic acidosis. In 
conclusion, these results demonstrate the importance of the functional coupling of 
TASK2 activity and proximal NaHCO3 transport via basolateral, extracellular 
alkalinization. In addition, TASK-2 might be another candidate gene for genetic defects 
of proximal tubular bicarbonate reabsorption which lead to the syndrome o “proximal 
renal tubular acidosis” (OMIM 603493) (Warth et al., 2004). 
 
 
4.2  Respiration of TASK-2-/- is affected during hypoxic conditions 
 
The ability to maintain an adequate supply of oxygen is essential for survival. In many 
mammalian species, the major peripheral sensory organs for monitoring arterial oxygen 
level are the carotid bodies. The carotid body contains chemoreceptors that respond to 
hypoxia, hypercapnia and changes in hydrogen ion concentration (Gonzalez et al., 
1994). Hypoxia activates the arterial oxygen receptors in the carotid bodies, which in 
turn stimulates the brainstem respiratory centre (via the carotid sinus nerve) and leads to 
a reflex increase in respiratory rate. The carotid body comprises clusters of ovoid type I 
(glomus) cells which are surrounded by glial-like type II (sustentacular) cells (for a 
review see (Gonzalez et al., 1994; Gronblad, 1983). It is generally accepted that type I 
cells are the initial sites of oxygen sensing. Hypoxia inhibits oxygen-sensitive K+ 
channels in type I cells, which in turn leads to depolarization and Ca2+ entry via voltage-
gated Ca2+ channels. The rise in intracellular [Ca2+] ([Ca2+]i) in turn triggers the release 
of multiple neurotransmitters from type I cells (Gonzalez et al., 1994; Prabhakar, 2000). 
Depolarization of type I cell during hypoxia has been suggested to involve the inhibition 
of several oxygen sensitive K+ currents, including TASK-like K+ channels. It has been 
shown that several types of voltage insensitive channel, TASK-1, TASK-2, TASK-3 and 
TRAAK, are expressed in type I cells of the rat carotid body. The so-called background 
leak K+ current is inhibited by hypoxia in the rat isolated glomus cells thereby initiating 
the signal transduction cascade for hypoxia sensing (Yamamoto et al., 2002). During my 
thesis work, I have performed a pilot study to elucidate the potential role of TASK-2 in 
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 oxygen sensing. We observed a larger scattering of the minute volumes of TASK-2 
knockout mice under normoxic and hypoxic conditions. Moreover, lowering of oxygen 
(less than 9%) in the plethysmography chamber led several TASK-2-/- mice to stop 
breathing although respiratory depression could not been detected in those animals 
before. These observations suggest an impairment of the respiratory response upon 
hypoxia in TASK-2 knockout mice; however, other reasons to stop respiration (e.g. 
overall reduced performance and health) have still to be ruled out. The presumable 
localization of TASK-2 in oxygen-sensing cells in the carotyd bodies (Yamamoto et al., 
2002) suggests that intact TASK-2 channels are required for the physiological cellular 
response to hypoxia. Based on the data presented here, a following-up study has now 
been started in Regensburg to examine TASK-2 expression in carotid bodies and central 
respiratory centres and the regulation of respiration in TASK-2 knockout mice in more 
detail.  
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